{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:58:51Z","timestamp":1783472331070,"version":"3.55.0"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/B\/NZ3\/02817"],"award-info":[{"award-number":["2019\/35\/B\/NZ3\/02817"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) has been known for years as a poisoning gas and until recently evoked mostly negative associations. However, the discovery of its gasotransmitter functions suggested its contribution to various physiological and pathological processes. Although H<jats:sub>2<\/jats:sub>S has been found to exert cytoprotective effects through modulation of antioxidant, anti-inflammatory, anti-apoptotic, and pro-angiogenic responses in a variety of conditions, its role in the pathophysiology of skeletal muscles has not been broadly elucidated so far. The classical example of muscle-related disorders is Duchenne muscular dystrophy (DMD), the most common and severe type of muscular dystrophy. Mutations in the<jats:italic>DMD<\/jats:italic>gene that encodes dystrophin, a cytoskeletal protein that protects muscle fibers from contraction-induced damage, lead to prominent dysfunctions in the structure and functions of the skeletal muscle. However, the main cause of death is associated with cardiorespiratory failure, and DMD remains an incurable disease. Taking into account a wide range of physiological functions of H<jats:sub>2<\/jats:sub>S and recent literature data on its possible protective role in DMD, we focused on the description of the \u2018old\u2019 and \u2018new\u2019 functions of H<jats:sub>2<\/jats:sub>S, especially in muscle pathophysiology. Although the number of studies showing its essential regulatory action in dystrophic muscles is still limited, we propose that H<jats:sub>2<\/jats:sub>S-based therapy has the potential to attenuate the progression of DMD and other muscle-related disorders.<\/jats:p>","DOI":"10.1007\/s00018-022-04636-0","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T11:04:06Z","timestamp":1669633446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases"],"prefix":"10.1007","volume":"79","author":[{"given":"Katarzyna","family":"Kazir\u00f3d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Myszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-0839","authenticated-orcid":false,"given":"J\u00f3zef","family":"Dulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3523-3560","authenticated-orcid":false,"given":"Agnieszka","family":"\u0141oboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"4636_CR1","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1111\/febs.15466","volume":"287","author":"EP Hoffman","year":"2020","unstructured":"Hoffman EP (2020) The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. FEBS J 287:3879\u20133887. https:\/\/doi.org\/10.1111\/febs.15466","journal-title":"FEBS J"},{"key":"4636_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17:251\u2013267. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"key":"4636_CR3","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533\u20132546. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.081","journal-title":"J Am Coll Cardiol"},{"key":"4636_CR4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s43440-020-00134-x","volume":"72","author":"A \u0141oboda","year":"2020","unstructured":"\u0141oboda A, Dulak J (2020) Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacol Rep 72:1227\u20131263. https:\/\/doi.org\/10.1007\/s43440-020-00134-x","journal-title":"Pharmacol Rep"},{"key":"4636_CR5","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","volume":"56","author":"P Kieny","year":"2013","unstructured":"Kieny P, Chollet S, Delalande P et al (2013) Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. Ann Phys Rehabil Med 56:443\u2013454. https:\/\/doi.org\/10.1016\/j.rehab.2013.06.002","journal-title":"Ann Phys Rehabil Med"},{"key":"4636_CR6","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.1007\/s00018-021-03862-2","volume":"78","author":"U Florczyk-Soluch","year":"2021","unstructured":"Florczyk-Soluch U, Polak K, Dulak J (2021) The multifaceted view of heart problem in Duchenne muscular dystrophy. Cell Mol Life Sci 78:5447\u20135468. https:\/\/doi.org\/10.1007\/s00018-021-03862-2","journal-title":"Cell Mol Life Sci"},{"key":"4636_CR7","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F (2019) Muscular dystrophies. Lancet 394:2025\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(19)32910-1","journal-title":"Lancet"},{"key":"4636_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S et al (2021) Duchenne muscular dystrophy. Nat Rev Dis Prim 7:13. https:\/\/doi.org\/10.1038\/s41572-021-00248-3","journal-title":"Nat Rev Dis Prim"},{"key":"4636_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0092-8674(87)90504-6","volume":"50","author":"M Koenig","year":"1987","unstructured":"Koenig M, Hoffman EP, Bertelson CJ et al (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509\u2013517. https:\/\/doi.org\/10.1016\/0092-8674(87)90504-6","journal-title":"Cell"},{"key":"4636_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/cphy.c140048","volume":"5","author":"QQ Gao","year":"2015","unstructured":"Gao QQ, McNally EM (2015) The dystrophin complex: structure, function, and implications for therapy. Compr Physiol 5:1223\u20131239. https:\/\/doi.org\/10.1002\/cphy.c140048","journal-title":"Compr Physiol"},{"key":"4636_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0014-5793(02)02613-3","volume":"517","author":"M Sironi","year":"2002","unstructured":"Sironi M, Cagliani R, Pozzoli U et al (2002) The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett 517:163\u2013166. https:\/\/doi.org\/10.1016\/S0014-5793(02)02613-3","journal-title":"FEBS Lett"},{"key":"4636_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbadis.2006.05.010","volume":"1772","author":"JM Ervasti","year":"2007","unstructured":"Ervasti JM (2007) Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772:108\u2013117. https:\/\/doi.org\/10.1016\/j.bbadis.2006.05.010","journal-title":"Biochim Biophys Acta"},{"key":"4636_CR13","doi-asserted-by":"publisher","DOI":"10.4172\/2329-6682.1000128","author":"A Bagchi","year":"2015","unstructured":"Bagchi A (2015) Domain wise distribution of mutations in dystrophin protein and Duchenne muscular dystrophy. Gene Technol. https:\/\/doi.org\/10.4172\/2329-6682.1000128","journal-title":"Gene Technol"},{"key":"4636_CR14","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","volume":"32","author":"MA Waldrop","year":"2019","unstructured":"Waldrop MA, Flanigan KM (2019) Update in Duchenne and Becker muscular dystrophy. Curr Opin Neurol 32:722\u2013727. https:\/\/doi.org\/10.1097\/WCO.0000000000000739","journal-title":"Curr Opin Neurol"},{"key":"4636_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.bbamem.2013.08.023","volume":"1838","author":"B Constantin","year":"2014","unstructured":"Constantin B (2014) Dystrophin complex functions as a scaffold for signalling proteins. Biochim Biophys Acta 1838:635\u2013642. https:\/\/doi.org\/10.1016\/j.bbamem.2013.08.023","journal-title":"Biochim Biophys Acta"},{"key":"4636_CR16","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman EP, Brown RH, Kunkel LM (1987) Dystrophin: the protein product of the duchenne muscular dystrophy locus. Cell 51:919\u2013928. https:\/\/doi.org\/10.1016\/0092-8674(87)90579-4","journal-title":"Cell"},{"key":"4636_CR17","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2015","unstructured":"Hathout Y, Brody E, Clemens PR et al (2015) Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci USA 112:7153\u20137158. https:\/\/doi.org\/10.1073\/pnas.1507719112","journal-title":"Proc Natl Acad Sci USA"},{"key":"4636_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0009-8981(85)90202-5","volume":"147","author":"MJ Jackson","year":"1985","unstructured":"Jackson MJ, Jones DA, Edwards RH (1985) Measurements of calcium and other elements in muscle biopsy samples from patients with Duchenne muscular dystrophy. Clin Chim Acta 147:215\u2013221. https:\/\/doi.org\/10.1016\/0009-8981(85)90202-5","journal-title":"Clin Chim Acta"},{"key":"4636_CR19","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1074\/jbc.M006337200","volume":"276","author":"V Robert","year":"2001","unstructured":"Robert V, Massimino ML, Tosello V et al (2001) Alteration in calcium handling at the subcellular level in mdx myotubes. J Biol Chem 276:4647\u20134651. https:\/\/doi.org\/10.1074\/jbc.M006337200","journal-title":"J Biol Chem"},{"key":"4636_CR20","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/jcm9020520","volume":"9","author":"ML Law","year":"2020","unstructured":"Law ML, Cohen H, Martin AA et al (2020) Dysregulation of calcium handling in duchenne muscular dystrophy-associated dilated cardiomyopathy: mechanisms and experimental therapeutic strategies. J Clin Med 9:520. https:\/\/doi.org\/10.3390\/jcm9020520","journal-title":"J Clin Med"},{"key":"4636_CR21","doi-asserted-by":"publisher","first-page":"8823","DOI":"10.3390\/molecules20058823","volume":"20","author":"T van Westering","year":"2015","unstructured":"van Westering T, Betts C, Wood M (2015) Current understanding of molecular pathology and treatment of cardiomyopathy in Duchenne muscular dystrophy. Molecules 20:8823\u20138855. https:\/\/doi.org\/10.3390\/molecules20058823","journal-title":"Molecules"},{"key":"4636_CR22","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1007\/s00018-021-03821-x","volume":"78","author":"A Starosta","year":"2021","unstructured":"Starosta A, Konieczny P (2021) Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci 78:4867\u20134891. https:\/\/doi.org\/10.1007\/s00018-021-03821-x","journal-title":"Cell Mol Life Sci"},{"key":"4636_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","volume":"8","author":"JG Tidball","year":"2018","unstructured":"Tidball JG, Welc SS, Wehling-Henricks M (2018) Immunobiology of inherited muscular dystrophies. Compr Physiol 8:1313\u20131356. https:\/\/doi.org\/10.1002\/cphy.c170052","journal-title":"Compr Physiol"},{"key":"4636_CR24","doi-asserted-by":"publisher","unstructured":"Rosenberg AS, Puig M, Nagaraju K et al (2015) Immune-mediated pathology in Duchenne muscular dystrophy. Science Transl Med 7:299rv4\u2013299rv4. https:\/\/doi.org\/10.1126\/scitranslmed.aaa7322","DOI":"10.1126\/scitranslmed.aaa7322"},{"key":"4636_CR25","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.celrep.2018.10.077","volume":"25","author":"G Juban","year":"2018","unstructured":"Juban G, Saclier M, Yacoub-Youssef H et al (2018) AMPK activation regulates LTBP4-dependent TGF-\u03b21 secretion by pro-inflammatory macrophages and controls fibrosis in Duchenne muscular dystrophy. Cell Rep 25:2163-2176.e6. https:\/\/doi.org\/10.1016\/j.celrep.2018.10.077","journal-title":"Cell Rep"},{"key":"4636_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2044-5040-1-21","volume":"1","author":"CJ Mann","year":"2011","unstructured":"Mann CJ, Perdiguero E, Kharraz Y et al (2011) Aberrant repair and fibrosis development in skeletal muscle. Skelet Muscle 1:21. https:\/\/doi.org\/10.1186\/2044-5040-1-21","journal-title":"Skelet Muscle"},{"key":"4636_CR27","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.2217\/bmm-2018-0125","volume":"12","author":"P Magrath","year":"2018","unstructured":"Magrath P, Maforo N, Renella P et al (2018) Cardiac MRI biomarkers for Duchenne muscular dystrophy. Biomark Med 12:1271\u20131289. https:\/\/doi.org\/10.2217\/bmm-2018-0125","journal-title":"Biomark Med"},{"key":"4636_CR28","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4161\/cc.9.11.11854","volume":"9","author":"A Natarajan","year":"2010","unstructured":"Natarajan A, Lemos DR, Rossi FMV (2010) Fibro\/adipogenic progenitors: a double-edged sword in skeletal muscle regeneration. Cell Cycle 9:2045\u20132046. https:\/\/doi.org\/10.4161\/cc.9.11.11854","journal-title":"Cell Cycle"},{"key":"4636_CR29","doi-asserted-by":"publisher","unstructured":"Grounds MD, Terrill JR, Al-Mshhdani BA et al (2020) Biomarkers for Duchenne muscular dystrophy: myonecrosis, inflammation and oxidative stress. Dis Model Mech 13:dmm043638. https:\/\/doi.org\/10.1242\/dmm.043638","DOI":"10.1242\/dmm.043638"},{"key":"4636_CR30","doi-asserted-by":"publisher","first-page":"16474","DOI":"10.1073\/pnas.1307680110","volume":"110","author":"J von Maltzahn","year":"2013","unstructured":"von Maltzahn J, Jones AE, Parks RJ, Rudnicki MA (2013) Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc Natl Acad Sci USA 110:16474\u201316479. https:\/\/doi.org\/10.1073\/pnas.1307680110","journal-title":"Proc Natl Acad Sci USA"},{"key":"4636_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J et al (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455\u20131463. https:\/\/doi.org\/10.1038\/nm.3990","journal-title":"Nat Med"},{"key":"4636_CR32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-010-0976-6","volume":"340","author":"M Kottlors","year":"2010","unstructured":"Kottlors M, Kirschner J (2010) Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res 340:541\u2013548. https:\/\/doi.org\/10.1007\/s00441-010-0976-6","journal-title":"Cell Tissue Res"},{"key":"4636_CR33","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2010.11.039","volume":"143","author":"A Sacco","year":"2010","unstructured":"Sacco A, Mourkioti F, Tran R et al (2010) Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx\/mTR mice. Cell 143:1059\u20131071. https:\/\/doi.org\/10.1016\/j.cell.2010.11.039","journal-title":"Cell"},{"key":"4636_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13395-019-0207-0","volume":"9","author":"I Bronisz-Budzy\u0144ska","year":"2019","unstructured":"Bronisz-Budzy\u0144ska I, Chwalenia K, Mucha O et al (2019) miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skelet Muscle 9:22. https:\/\/doi.org\/10.1186\/s13395-019-0207-0","journal-title":"Skelet Muscle"},{"key":"4636_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13395-020-00255-0","volume":"10","author":"I Bronisz-Budzy\u0144ska","year":"2020","unstructured":"Bronisz-Budzy\u0144ska I, Kozakowska M, Podkalicka P et al (2020) The role of Nrf2 in acute and chronic muscle injury. Skelet Muscle 10:35. https:\/\/doi.org\/10.1186\/s13395-020-00255-0","journal-title":"Skelet Muscle"},{"key":"4636_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13395-021-00276-3","volume":"11","author":"O Mucha","year":"2021","unstructured":"Mucha O, Podkalicka P, Kazir\u00f3d K et al (2021) Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy. Skelet Muscle 11:21. https:\/\/doi.org\/10.1186\/s13395-021-00276-3","journal-title":"Skelet Muscle"},{"key":"4636_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.312","volume":"5","author":"C De Palma","year":"2014","unstructured":"De Palma C, Morisi F, Cheli S et al (2014) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 5:e1363. https:\/\/doi.org\/10.1038\/cddis.2014.312","journal-title":"Cell Death Dis"},{"key":"4636_CR38","doi-asserted-by":"publisher","unstructured":"Spitali P, Grumati P, Hiller M et al (2013) Autophagy is impaired in the tibialis anterior of dystrophin null mice. PLoS Curr 5:ecurrents.md.e1226cefa851a2f079bbc406c0a21e80. https:\/\/doi.org\/10.1371\/currents.md.e1226cefa851a2f079bbc406c0a21e80","DOI":"10.1371\/currents.md.e1226cefa851a2f079bbc406c0a21e80"},{"key":"4636_CR39","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.stem.2018.03.022","volume":"22","author":"NC Chang","year":"2018","unstructured":"Chang NC, Sincennes M-C, Chevalier FP et al (2018) The dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell commitment. Cell Stem Cell 22:755-768.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.03.022","journal-title":"Cell Stem Cell"},{"key":"4636_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature18014","volume":"534","author":"H-JR Shin","year":"2016","unstructured":"Shin H-JR, Kim H, Oh S et al (2016) AMPK\u2013SKP2\u2013CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534:553\u2013557. https:\/\/doi.org\/10.1038\/nature18014","journal-title":"Nature"},{"key":"4636_CR41","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1242\/jcs.114041","volume":"126","author":"M Sandri","year":"2013","unstructured":"Sandri M, Coletto L, Grumati P, Bonaldo P (2013) Misregulation of autophagy and protein degradation systems in myopathies and muscular dystrophies. J Cell Sci 126:5325\u20135333. https:\/\/doi.org\/10.1242\/jcs.114041","journal-title":"J Cell Sci"},{"key":"4636_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3390\/ijms23010470","volume":"23","author":"O Mucha","year":"2021","unstructured":"Mucha O, Kazir\u00f3d K, Podkalicka P et al (2021) Dysregulated autophagy and mitophagy in a mouse model of duchenne muscular dystrophy remain unchanged following heme oxygenase-1 knockout. Int J Mol Sci 23:470. https:\/\/doi.org\/10.3390\/ijms23010470","journal-title":"Int J Mol Sci"},{"key":"4636_CR43","first-page":"781","volume":"22","author":"P Gim\u00e9nez-Xavier","year":"2008","unstructured":"Gim\u00e9nez-Xavier P, Francisco R, Platini F et al (2008) LC3-I conversion to LC3-II does not necessarily result in complete autophagy. Int J Mol Med 22:781\u2013785","journal-title":"Int J Mol Med"},{"key":"4636_CR44","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3389\/fphys.2020.00690","volume":"11","author":"TM Moore","year":"2020","unstructured":"Moore TM, Lin AJ, Strumwasser AR et al (2020) Mitochondrial dysfunction is an early consequence of partial or complete dystrophin loss in mdx mice. Front Physiol 11:690. https:\/\/doi.org\/10.3389\/fphys.2020.00690","journal-title":"Front Physiol"},{"key":"4636_CR45","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.2174\/1381612824666180727100909","volume":"24","author":"LR Vasconcellos","year":"2018","unstructured":"Vasconcellos LR, Siqueira MS, Moraes R et al (2018) Heme oxygenase-1 and autophagy linked for cytoprotection. Curr Pharm Des 24:2311\u20132316. https:\/\/doi.org\/10.2174\/1381612824666180727100909","journal-title":"Curr Pharm Des"},{"key":"4636_CR46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvx201","volume":"114","author":"C Kang","year":"2018","unstructured":"Kang C, Badr MA, Kyrychenko V et al (2018) Deficit in PINK1\/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovasc Res 114:90\u2013102. https:\/\/doi.org\/10.1093\/cvr\/cvx201","journal-title":"Cardiovasc Res"},{"key":"4636_CR47","doi-asserted-by":"publisher","unstructured":"Luan P, D\u2019Amico D, Andreux PA et al (2021) Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. Sci Transl Med 13:eabb0319. https:\/\/doi.org\/10.1126\/scitranslmed.abb0319","DOI":"10.1126\/scitranslmed.abb0319"},{"key":"4636_CR48","doi-asserted-by":"publisher","first-page":"15555","DOI":"10.1038\/s41598-018-33930-w","volume":"8","author":"A Kuno","year":"2018","unstructured":"Kuno A, Hosoda R, Sebori R et al (2018) Resveratrol ameliorates mitophagy disturbance and improves cardiac pathophysiology of dystrophin-deficient mdx mice. Sci Rep 8:15555. https:\/\/doi.org\/10.1038\/s41598-018-33930-w","journal-title":"Sci Rep"},{"key":"4636_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ajpath.2012.04.004","volume":"181","author":"M Pauly","year":"2012","unstructured":"Pauly M, Daussin F, Burelle Y et al (2012) AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol 181:583\u2013592. https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.004","journal-title":"Am J Pathol"},{"key":"4636_CR50","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00018-019-03006-7","volume":"76","author":"P Podkalicka","year":"2019","unstructured":"Podkalicka P, Mucha O, Dulak J, Loboda A (2019) Targeting angiogenesis in Duchenne muscular dystrophy. Cell Mol Life Sci 76:1507\u20131528. https:\/\/doi.org\/10.1007\/s00018-019-03006-7","journal-title":"Cell Mol Life Sci"},{"key":"4636_CR51","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1091\/mbc.e06-08-0693","volume":"18","author":"C Christov","year":"2007","unstructured":"Christov C, Chr\u00e9tien F, Abou-Khalil R et al (2007) Muscle satellite cells and endothelial cells: close neighbors and privileged partners. MBoC 18:1397\u20131409. https:\/\/doi.org\/10.1091\/mbc.e06-08-0693","journal-title":"MBoC"},{"key":"4636_CR52","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1006\/cbir.1994.1015","volume":"18","author":"M-C Harricane","year":"1994","unstructured":"Harricane M-C, Febris E, Lees D et al (1994) Dystrophin does not influence regular cytoskeletal architecture but is required for contractile performance in smooth muscle aortic cells. Cell Biol Int 18:947\u2013958. https:\/\/doi.org\/10.1006\/cbir.1994.1015","journal-title":"Cell Biol Int"},{"key":"4636_CR53","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.CIR.103.6.864","volume":"103","author":"L Loufrani","year":"2001","unstructured":"Loufrani L, Matrougui K, Gorny D et al (2001) Flow (shear stress)\u2013induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 103:864\u2013870. https:\/\/doi.org\/10.1161\/01.CIR.103.6.864","journal-title":"Circulation"},{"key":"4636_CR54","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/path.5704","volume":"254","author":"K Kodippili","year":"2021","unstructured":"Kodippili K, Thorne PK, Laughlin MH, Duan D (2021) Dystrophin deficiency impairs vascular structure and function in the canine model of Duchenne muscular dystrophy. J Pathol 254:589\u2013605. https:\/\/doi.org\/10.1002\/path.5704","journal-title":"J Pathol"},{"key":"4636_CR55","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.ajpath.2015.05.009","volume":"185","author":"C Latroche","year":"2015","unstructured":"Latroche C, Matot B, Martins-Bach A et al (2015) Structural and functional alterations of skeletal muscle microvasculature in dystrophin-deficient mdx mice. Am J Pathol 185:2482\u20132494. https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.009","journal-title":"Am J Pathol"},{"key":"4636_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/biomedicines9050481","volume":"9","author":"P Podkalicka","year":"2021","unstructured":"Podkalicka P, Mucha O, Kazir\u00f3d K et al (2021) Age-dependent dysregulation of muscle vasculature and blood flow recovery after hindlimb ischemia in the mdx model of duchenne muscular dystrophy. Biomedicines 9:481. https:\/\/doi.org\/10.3390\/biomedicines9050481","journal-title":"Biomedicines"},{"key":"4636_CR57","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fgene.2018.00114","volume":"9","author":"G Cordova","year":"2018","unstructured":"Cordova G, Negroni E, Cabello-Verrugio C et al (2018) Combined therapies for Duchenne muscular dystrophy to optimize treatment efficacy. Front Genet 9:114. https:\/\/doi.org\/10.3389\/fgene.2018.00114","journal-title":"Front Genet"},{"key":"4636_CR58","doi-asserted-by":"publisher","first-page":"14038","DOI":"10.1038\/mtm.2014.38","volume":"1","author":"AL Arnett","year":"2014","unstructured":"Arnett AL, Konieczny P, Ramos JN et al (2014) Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Mol Ther Methods Clin Dev 1:14038. https:\/\/doi.org\/10.1038\/mtm.2014.38","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4636_CR59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar M, Zhu K, Cheng JKW et al (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351:407\u2013411. https:\/\/doi.org\/10.1126\/science.aad5177","journal-title":"Science"},{"key":"4636_CR60","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","volume":"19","author":"JB Kwon","year":"2020","unstructured":"Kwon JB, Ettyreddy AR, Vankara A et al (2020) In vivo gene editing of muscle stem cells with adeno-associated viral vectors in a mouse model of duchenne muscular dystrophy. Mol Ther Methods Clin Dev 19:320\u2013329. https:\/\/doi.org\/10.1016\/j.omtm.2020.09.016","journal-title":"Mol Ther Methods Clin Dev"},{"key":"4636_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JND-180357","volume":"6","author":"A Aartsma-Rus","year":"2019","unstructured":"Aartsma-Rus A, Morgan J, Lonkar P et al (2019) Report of a TREAT-NMD\/World Duchenne organisation meeting on dystrophin quantification methodology. J Neuromuscul Dis 6:147\u2013159. https:\/\/doi.org\/10.3233\/JND-180357","journal-title":"J Neuromuscul Dis"},{"key":"4636_CR62","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nm0302-253","volume":"8","author":"SQ Harper","year":"2002","unstructured":"Harper SQ, Hauser MA, DelloRusso C et al (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8:253\u2013261. https:\/\/doi.org\/10.1038\/nm0302-253","journal-title":"Nat Med"},{"key":"4636_CR63","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0006-291X(02)00362-5","volume":"293","author":"M Sakamoto","year":"2002","unstructured":"Sakamoto M, Yuasa K, Yoshimura M et al (2002) Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 293:1265\u20131272. https:\/\/doi.org\/10.1016\/S0006-291X(02)00362-5","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR64","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan D (2018) Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol Ther 26:2337\u20132356. https:\/\/doi.org\/10.1016\/j.ymthe.2018.07.011","journal-title":"Mol Ther"},{"key":"4636_CR65","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","volume":"363","author":"JR Mendell","year":"2010","unstructured":"Mendell JR, Campbell K, Rodino-Klapac L et al (2010) Dystrophin immunity in Duchenne\u2019s muscular dystrophy. N Engl J Med 363:1429\u20131437. https:\/\/doi.org\/10.1056\/NEJMoa1000228","journal-title":"N Engl J Med"},{"key":"4636_CR66","doi-asserted-by":"publisher","unstructured":"Mendell JR, Sahenk Z, Lehman K, et al (2020) Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in children with Duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1484","DOI":"10.1001\/jamaneurol.2020.1484"},{"key":"4636_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/339055a0","volume":"339","author":"DR Love","year":"1989","unstructured":"Love DR, Hill DF, Dickson G et al (1989) An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339:55\u201358. https:\/\/doi.org\/10.1038\/339055a0","journal-title":"Nature"},{"key":"4636_CR68","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF02388063","volume":"25","author":"A Clerk","year":"1993","unstructured":"Clerk A, Morris GE, Dubowitz V et al (1993) Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem J 25:554\u2013561","journal-title":"Histochem J"},{"key":"4636_CR69","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/aja.1001980403","volume":"198","author":"J Schofield","year":"1993","unstructured":"Schofield J, Houzelstein D, Davies K et al (1993) Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis. Dev Dyn 198:254\u2013264. https:\/\/doi.org\/10.1002\/aja.1001980403","journal-title":"Dev Dyn"},{"key":"4636_CR70","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/360588a0","volume":"360","author":"K Matsumura","year":"1992","unstructured":"Matsumura K, Ervasti JM, Ohlendieck K et al (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360:588\u2013591. https:\/\/doi.org\/10.1038\/360588a0","journal-title":"Nature"},{"key":"4636_CR71","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/hmg\/2.11.1765","volume":"2","author":"M Pearce","year":"1993","unstructured":"Pearce M, Blake DJ, Tinsley JM et al (1993) The utrophin and dystrophin genes share similarities in genomic structure. Hum Mol Genet 2:1765\u20131772. https:\/\/doi.org\/10.1093\/hmg\/2.11.1765","journal-title":"Hum Mol Genet"},{"key":"4636_CR72","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1242\/jcs.064808","volume":"123","author":"D Li","year":"2010","unstructured":"Li D, Bareja A, Judge L et al (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci 123:2008\u20132013. https:\/\/doi.org\/10.1242\/jcs.064808","journal-title":"J Cell Sci"},{"key":"4636_CR73","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","volume":"28","author":"S Guiraud","year":"2019","unstructured":"Guiraud S, Edwards B, Babbs A et al (2019) The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Hum Mol Genet 28:2189\u20132200. https:\/\/doi.org\/10.1093\/hmg\/ddz049","journal-title":"Hum Mol Genet"},{"key":"4636_CR74","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nrneurol.2016.180","volume":"12","author":"JJ Dowling","year":"2016","unstructured":"Dowling JJ (2016) Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line. Nat Rev Neurol 12:675\u2013676. https:\/\/doi.org\/10.1038\/nrneurol.2016.180","journal-title":"Nat Rev Neurol"},{"key":"4636_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1126\/science.aba4515","volume":"371","author":"A Ferlini","year":"2021","unstructured":"Ferlini A, Goyenvalle A, Muntoni F (2021) RNA-targeted drugs for neuromuscular diseases. Science 371:29\u201331. https:\/\/doi.org\/10.1126\/science.aba4515","journal-title":"Science"},{"key":"4636_CR76","doi-asserted-by":"publisher","unstructured":"Dulak J (2021) Gene therapy. The legacy of Wac\u0142aw Szybalski. Acta Biochim Pol 68:359\u2013375. https:\/\/doi.org\/10.18388\/abp.2020_5805","DOI":"10.18388\/abp.2020_5805"},{"key":"4636_CR77","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41434-020-0156-6","volume":"27","author":"K Dzierlega","year":"2020","unstructured":"Dzierlega K, Yokota T (2020) Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy. Gene Ther 27:407\u2013416. https:\/\/doi.org\/10.1038\/s41434-020-0156-6","journal-title":"Gene Ther"},{"key":"4636_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/nat.2013.0451","volume":"24","author":"Y Echigoya","year":"2014","unstructured":"Echigoya Y, Yokota T (2014) Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides. Nucleic Acid Ther 24:57\u201368. https:\/\/doi.org\/10.1089\/nat.2013.0451","journal-title":"Nucleic Acid Ther"},{"key":"4636_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010001","author":"T Aslesh","year":"2018","unstructured":"Aslesh T, Maruyama R, Yokota T (2018) Skipping multiple exons to treat DMD-promises and challenges. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines6010001","journal-title":"Biomedicines"},{"key":"4636_CR80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.24332","volume":"50","author":"K Bushby","year":"2014","unstructured":"Bushby K, Finkel R, Wong B et al (2014) Ataluren treatment of patients with nonsense mutation dystrophinopathy. Muscle Nerve 50:477\u2013487. https:\/\/doi.org\/10.1002\/mus.24332","journal-title":"Muscle Nerve"},{"key":"4636_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/jpm9010016","author":"A Nakamura","year":"2019","unstructured":"Nakamura A (2019) Mutation-based therapeutic strategies for Duchenne muscular dystrophy: from genetic diagnosis to therapy. J Pers Med. https:\/\/doi.org\/10.3390\/jpm9010016","journal-title":"J Pers Med"},{"key":"4636_CR82","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/ph14080785","volume":"14","author":"S Michorowska","year":"2021","unstructured":"Michorowska S (2021) Ataluren-promising therapeutic premature termination codon readthrough frontrunner. Pharmaceuticals (Basel) 14:785. https:\/\/doi.org\/10.3390\/ph14080785","journal-title":"Pharmaceuticals (Basel)"},{"key":"4636_CR83","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.stem.2016.01.021","volume":"18","author":"CS Young","year":"2016","unstructured":"Young CS, Hicks MR, Ermolova NV et al (2016) A Single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells. Cell Stem Cell 18:533\u2013540. https:\/\/doi.org\/10.1016\/j.stem.2016.01.021","journal-title":"Cell Stem Cell"},{"key":"4636_CR84","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","volume":"70","author":"Y-L Min","year":"2019","unstructured":"Min Y-L, Bassel-Duby R, Olson EN (2019) CRISPR correction of Duchenne muscular dystrophy. Annu Rev Med 70:239\u2013255. https:\/\/doi.org\/10.1146\/annurev-med-081117-010451","journal-title":"Annu Rev Med"},{"key":"4636_CR85","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.aad5143","volume":"351","author":"CE Nelson","year":"2016","unstructured":"Nelson CE, Hakim CH, Ousterout DG et al (2016) In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351:403\u2013407. https:\/\/doi.org\/10.1126\/science.aad5143","journal-title":"Science"},{"key":"4636_CR86","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1126\/science.aad5725","volume":"351","author":"C Long","year":"2016","unstructured":"Long C, Amoasii L, Mireault AA et al (2016) Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351:400\u2013403. https:\/\/doi.org\/10.1126\/science.aad5725","journal-title":"Science"},{"key":"4636_CR87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.aau1549","volume":"362","author":"L Amoasii","year":"2018","unstructured":"Amoasii L, Hildyard JCW, Li H et al (2018) Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy. Science 362:86\u201391. https:\/\/doi.org\/10.1126\/science.aau1549","journal-title":"Science"},{"key":"4636_CR88","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti A, Fonteyne L, Giesert F et al (2020) Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat Med 26:207\u2013214. https:\/\/doi.org\/10.1038\/s41591-019-0738-2","journal-title":"Nat Med"},{"key":"4636_CR89","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.omtn.2022.03.004","volume":"28","author":"DR Karri","year":"2022","unstructured":"Karri DR, Zhang Y, Chemello F et al (2022) Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice. Mol Ther Nucleic Acids 28:154\u2013167. https:\/\/doi.org\/10.1016\/j.omtn.2022.03.004","journal-title":"Mol Ther Nucleic Acids"},{"key":"4636_CR90","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jbiotec.2018.08.007","volume":"284","author":"ML Kimberland","year":"2018","unstructured":"Kimberland ML, Hou W, Alfonso-Pecchio A et al (2018) Strategies for controlling CRISPR\/Cas9 off-target effects and biological variations in mammalian genome editing experiments. J Biotechnol 284:91\u2013101. https:\/\/doi.org\/10.1016\/j.jbiotec.2018.08.007","journal-title":"J Biotechnol"},{"key":"4636_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"X-H Zhang","year":"2015","unstructured":"Zhang X-H, Tee LY, Wang X-G et al (2015) Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol Ther Nucleic Acids 4:e264. https:\/\/doi.org\/10.1038\/mtna.2015.37","journal-title":"Mol Ther Nucleic Acids"},{"key":"4636_CR92","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2004840117","volume":"118","author":"EN Olson","year":"2021","unstructured":"Olson EN (2021) Toward the correction of muscular dystrophy by gene editing. Proc Natl Acad Sci USA 118:e2004840117. https:\/\/doi.org\/10.1073\/pnas.2004840117","journal-title":"Proc Natl Acad Sci USA"},{"key":"4636_CR93","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/ijms23031832","volume":"23","author":"E Erkut","year":"2022","unstructured":"Erkut E, Yokota T (2022) CRISPR therapeutics for Duchenne muscular dystrophy. Int J Mol Sci 23:1832. https:\/\/doi.org\/10.3390\/ijms23031832","journal-title":"Int J Mol Sci"},{"key":"4636_CR94","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nature05282","volume":"444","author":"M Sampaolesi","year":"2006","unstructured":"Sampaolesi M, Blot S, D\u2019Antona G et al (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574\u2013579. https:\/\/doi.org\/10.1038\/nature05282","journal-title":"Nature"},{"key":"4636_CR95","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1242\/dev.129.11.2773","volume":"129","author":"MG Minasi","year":"2002","unstructured":"Minasi MG, Riminucci M, De Angelis L et al (2002) The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 129:2773\u20132783. https:\/\/doi.org\/10.1242\/dev.129.11.2773","journal-title":"Development"},{"key":"4636_CR96","doi-asserted-by":"publisher","unstructured":"Cossu G, Previtali SC, Napolitano S et al (2015) Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy. EMBO Mol Med 7:1513\u20131528. https:\/\/doi.org\/10.15252\/emmm.201505636","DOI":"10.15252\/emmm.201505636"},{"key":"4636_CR97","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/mt.2014.26","volume":"22","author":"J Meng","year":"2014","unstructured":"Meng J, Chun S, Asfahani R et al (2014) Human skeletal muscle-derived CD133+ cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice. Mol Ther 22:1008\u20131017. https:\/\/doi.org\/10.1038\/mt.2014.26","journal-title":"Mol Ther"},{"key":"4636_CR98","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/mt.2009.167","volume":"17","author":"E Negroni","year":"2009","unstructured":"Negroni E, Riederer I, Chaouch S et al (2009) In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 17:1771\u20131778. https:\/\/doi.org\/10.1038\/mt.2009.167","journal-title":"Mol Ther"},{"key":"4636_CR99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI20325","volume":"114","author":"Y Torrente","year":"2004","unstructured":"Torrente Y, Belicchi M, Sampaolesi M et al (2004) Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Investig 114:182\u2013195. https:\/\/doi.org\/10.1172\/JCI20325","journal-title":"J Clin Investig"},{"key":"4636_CR100","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMra1716145","volume":"380","author":"HM Blau","year":"2019","unstructured":"Blau HM, Daley GQ (2019) Stem cells in the treatment of disease. N Engl J Med 380:1748\u20131760. https:\/\/doi.org\/10.1056\/NEJMra1716145","journal-title":"N Engl J Med"},{"key":"4636_CR101","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/cphy.c140068","volume":"5","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Bentzinger CF, Sincennes M-C, Rudnicki MA (2015) Satellite cells and skeletal muscle regeneration. Compr Physiol 5:1027\u20131059. https:\/\/doi.org\/10.1002\/cphy.c140068","journal-title":"Compr Physiol"},{"key":"4636_CR102","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","volume":"320","author":"JR Mendell","year":"1989","unstructured":"Mendell JR, Moxley RT, Griggs RC et al (1989) Randomized, double-blind six-month trial of prednisone in Duchenne\u2019s muscular dystrophy. N Engl J Med 320:1592\u20131597. https:\/\/doi.org\/10.1056\/NEJM198906153202405","journal-title":"N Engl J Med"},{"key":"4636_CR103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13023-021-01758-9","volume":"16","author":"S Kourakis","year":"2021","unstructured":"Kourakis S, Timpani CA, Campelj DG et al (2021) Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: can we do better? Orphanet J Rare Dis 16:117. https:\/\/doi.org\/10.1186\/s13023-021-01758-9","journal-title":"Orphanet J Rare Dis"},{"key":"4636_CR104","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","volume":"16","author":"WD Biggar","year":"2006","unstructured":"Biggar WD, Harris VA, Eliasoph L, Alman B (2006) Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 16:249\u2013255. https:\/\/doi.org\/10.1016\/j.nmd.2006.01.010","journal-title":"Neuromuscul Disord"},{"key":"4636_CR105","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.2147\/DDDT.S110163","volume":"10","author":"S Miyatake","year":"2016","unstructured":"Miyatake S, Shimizu-Motohashi Y, Takeda S, Aoki Y (2016) Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors. Drug Des Dev Ther 10:2745\u20132758. https:\/\/doi.org\/10.2147\/DDDT.S110163","journal-title":"Drug Des Dev Ther"},{"key":"4636_CR106","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1096\/fj.04-1859fje","volume":"18","author":"SJG St-Pierre","year":"2004","unstructured":"St-Pierre SJG, Chakkalakal JV, Kolodziejczyk SM et al (2004) Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin\/NF-AT pathway. FASEB J 18:1937\u20131939. https:\/\/doi.org\/10.1096\/fj.04-1859fje","journal-title":"FASEB J"},{"key":"4636_CR107","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.3389\/fphar.2018.01402","volume":"9","author":"T Kameyama","year":"2018","unstructured":"Kameyama T, Ohuchi K, Funato M et al (2018) Efficacy of prednisolone in generated myotubes derived from fibroblasts of Duchenne muscular dystrophy patients. Front Pharmacol 9:1402. https:\/\/doi.org\/10.3389\/fphar.2018.01402","journal-title":"Front Pharmacol"},{"key":"4636_CR108","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1172\/JCI91445","volume":"127","author":"M Quattrocelli","year":"2017","unstructured":"Quattrocelli M, Barefield DY, Warner JL et al (2017) Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Investig 127:2418\u20132432. https:\/\/doi.org\/10.1172\/JCI91445","journal-title":"J Clin Investig"},{"key":"4636_CR109","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpn.2008.02.006","volume":"13","author":"S Mavrogeni","year":"2009","unstructured":"Mavrogeni S, Papavasiliou A, Douskou M et al (2009) Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: a magnetic resonance imaging study. Eur J Paediatr Neurol 13:34\u201340. https:\/\/doi.org\/10.1016\/j.ejpn.2008.02.006","journal-title":"Eur J Paediatr Neurol"},{"key":"4636_CR110","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2012.12.008","volume":"61","author":"G Schram","year":"2013","unstructured":"Schram G, Fournier A, Leduc H et al (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948\u2013954. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.008","journal-title":"J Am Coll Cardiol"},{"key":"4636_CR111","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0002-9149(02)03429-x","volume":"91","author":"CK Silversides","year":"2003","unstructured":"Silversides CK, Webb GD, Harris VA, Biggar DW (2003) Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy. Am J Cardiol 91:769\u2013772. https:\/\/doi.org\/10.1016\/s0002-9149(02)03429-x","journal-title":"Am J Cardiol"},{"key":"4636_CR112","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/emmm.201302621","volume":"5","author":"CR Heier","year":"2013","unstructured":"Heier CR, Damsker JM, Yu Q et al (2013) VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol Med 5:1569\u20131585. https:\/\/doi.org\/10.1002\/emmm.201302621","journal-title":"EMBO Mol Med"},{"key":"4636_CR113","doi-asserted-by":"publisher","first-page":"e1312","DOI":"10.1212\/WNL.0000000000008168","volume":"93","author":"EP Hoffman","year":"2019","unstructured":"Hoffman EP, Schwartz BD, Mengle-Gaw LJ et al (2019) Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function. Neurology 93:e1312\u2013e1323. https:\/\/doi.org\/10.1212\/WNL.0000000000008168","journal-title":"Neurology"},{"key":"4636_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003222","volume":"17","author":"EC Smith","year":"2020","unstructured":"Smith EC, Conklin LS, Hoffman EP et al (2020) Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study. PLoS Med 17:e1003222. https:\/\/doi.org\/10.1371\/journal.pmed.1003222","journal-title":"PLoS Med"},{"key":"4636_CR115","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1002\/jcph.1632","volume":"60","author":"X Li","year":"2020","unstructured":"Li X, Conklin LS, van den Anker J et al (2020) Exposure-response analysis of vamorolone (VBP15) in boys with duchenne muscular dystrophy. J Clin Pharmacol 60:1385\u20131396. https:\/\/doi.org\/10.1002\/jcph.1632","journal-title":"J Clin Pharmacol"},{"key":"4636_CR116","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4315","author":"M Guglieri","year":"2022","unstructured":"Guglieri M, Bushby K, McDermott MP et al (2022) Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2022.4315","journal-title":"JAMA"},{"key":"4636_CR117","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","volume":"16","author":"R Wang","year":"2002","unstructured":"Wang R (2002) Two\u2019s company, three\u2019s a crowd: can H 2 S be the third endogenous gaseous transmitter? FASEB j 16:1792\u20131798. https:\/\/doi.org\/10.1096\/fj.02-0211hyp","journal-title":"FASEB j"},{"key":"4636_CR118","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s13181-019-00710-5","volume":"15","author":"PC Ng","year":"2019","unstructured":"Ng PC, Hendry-Hofer TB, Witeof AE et al (2019) Hydrogen sulfide toxicity: mechanism of action, clinical presentation, and countermeasure development. J Med Toxicol 15:287\u2013294. https:\/\/doi.org\/10.1007\/s13181-019-00710-5","journal-title":"J Med Toxicol"},{"key":"4636_CR119","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coph.2019.07.001","volume":"45","author":"KD Hendriks","year":"2019","unstructured":"Hendriks KD, Maassen H, van Dijk PR et al (2019) Gasotransmitters in health and disease: a mitochondria-centered view. Curr Opin Pharmacol 45:87\u201393. https:\/\/doi.org\/10.1016\/j.coph.2019.07.001","journal-title":"Curr Opin Pharmacol"},{"key":"4636_CR120","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/152308603768295249","volume":"5","author":"R Wang","year":"2003","unstructured":"Wang R (2003) The gasotransmitter role of hydrogen sulfide. Antioxid Redox Signal 5:493\u2013501. https:\/\/doi.org\/10.1089\/152308603768295249","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR121","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00018-016-2406-8","volume":"74","author":"P Rose","year":"2017","unstructured":"Rose P, Moore PK, Zhu YZ (2017) H2S biosynthesis and catabolism: new insights from molecular studies. Cell Mol Life Sci 74:1391\u20131412. https:\/\/doi.org\/10.1007\/s00018-016-2406-8","journal-title":"Cell Mol Life Sci"},{"key":"4636_CR122","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.phrs.2016.08.026","volume":"113","author":"A Katsouda","year":"2016","unstructured":"Katsouda A, Bibli S-I, Pyriochou A et al (2016) Regulation and role of endogenously produced hydrogen sulfide in angiogenesis. Pharmacol Res 113:175\u2013185. https:\/\/doi.org\/10.1016\/j.phrs.2016.08.026","journal-title":"Pharmacol Res"},{"key":"4636_CR123","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1111\/bph.14358","volume":"175","author":"V Vellecco","year":"2018","unstructured":"Vellecco V, Armogida C, Bucci M (2018) Hydrogen sulfide pathway and skeletal muscle: an introductory review: Hydrogen sulfide and skeletal muscle. Br J Pharmacol 175:3090\u20133099. https:\/\/doi.org\/10.1111\/bph.14358","journal-title":"Br J Pharmacol"},{"key":"4636_CR124","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ncomms2371","volume":"4","author":"N Shibuya","year":"2013","unstructured":"Shibuya N, Koike S, Tanaka M et al (2013) A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nat Commun 4:1366. https:\/\/doi.org\/10.1038\/ncomms2371","journal-title":"Nat Commun"},{"key":"4636_CR125","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/ars.2014.5869","volume":"22","author":"H Kimura","year":"2015","unstructured":"Kimura H (2015) Signaling molecules: hydrogen sulfide and polysulfide. Antioxid Redox Signal 22:362\u2013376. https:\/\/doi.org\/10.1089\/ars.2014.5869","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2017.01.010","volume":"64","author":"LKM Souza","year":"2017","unstructured":"Souza LKM, Ara\u00fajo TSL, Sousa NA et al (2017) Evidence that d-cysteine protects mice from gastric damage via hydrogen sulfide produced by d-amino acid oxidase. Nitric Oxide 64:1\u20136. https:\/\/doi.org\/10.1016\/j.niox.2017.01.010","journal-title":"Nitric Oxide"},{"key":"4636_CR127","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41467-017-01311-y","volume":"8","author":"T Akaike","year":"2017","unstructured":"Akaike T, Ida T, Wei F-Y et al (2017) Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergetics. Nat Commun 8:1177. https:\/\/doi.org\/10.1038\/s41467-017-01311-y","journal-title":"Nat Commun"},{"key":"4636_CR128","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41588-017-0006-7","volume":"50","author":"A Pol","year":"2018","unstructured":"Pol A, Renkema GH, Tangerman A et al (2018) Mutations in SELENBP1, encoding a novel human methanethiol oxidase, cause extraoral halitosis. Nat Genet 50:120\u2013129. https:\/\/doi.org\/10.1038\/s41588-017-0006-7","journal-title":"Nat Genet"},{"key":"4636_CR129","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1582-4934.2009.00645.x","volume":"13","author":"M Whiteman","year":"2009","unstructured":"Whiteman M, Moore PK (2009) Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavailability? J Cell Mol Med 13:488\u2013507. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00645.x","journal-title":"J Cell Mol Med"},{"key":"4636_CR130","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00028.2021","author":"G Cirino","year":"2022","unstructured":"Cirino G, Szabo C, Papapetropoulos A (2022) Physiological roles of hydrogen sulfide in mammalian cells, tissues and organs. Physiol Rev. https:\/\/doi.org\/10.1152\/physrev.00028.2021","journal-title":"Physiol Rev"},{"key":"4636_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/1873962","volume":"2018","author":"U Shefa","year":"2018","unstructured":"Shefa U, Kim M-S, Jeong NY, Jung J (2018) Antioxidant and cell-signaling functions of hydrogen sulfide in the central nervous system. Oxid Med Cell Longev 2018:1\u201317. https:\/\/doi.org\/10.1155\/2018\/1873962","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR132","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1089\/ars.2020.8211","volume":"34","author":"M Bhatia","year":"2021","unstructured":"Bhatia M, Gaddam RR (2021) Hydrogen sulfide in inflammation: a novel mediator and therapeutic target. Antioxid Redox Signal 34:1368\u20131377. https:\/\/doi.org\/10.1089\/ars.2020.8211","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR133","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2003.11.081","volume":"313","author":"H Yan","year":"2004","unstructured":"Yan H, Du J, Tang C (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 313:22\u201327. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.081","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4579140","volume":"2018","author":"D Wu","year":"2018","unstructured":"Wu D, Hu Q, Zhu D (2018) An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system. Oxid Med Cell Longev 2018:1\u201316. https:\/\/doi.org\/10.1155\/2018\/4579140","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR135","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/157016106775203144","volume":"4","author":"C Tang","year":"2006","unstructured":"Tang C, Li X, Du J (2006) Hydrogen sulfide as a new endogenous gaseous transmitter in the cardiovascular system. CVP 4:17\u201322. https:\/\/doi.org\/10.2174\/157016106775203144","journal-title":"CVP"},{"key":"4636_CR136","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.112.000855","volume":"127","author":"K Kondo","year":"2013","unstructured":"Kondo K, Bhushan S, King AL et al (2013) H2S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 127:1116\u20131127. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.000855","journal-title":"Circulation"},{"key":"4636_CR137","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fphar.2017.00608","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Du J, Tang C et al (2017) H2S-induced sulfhydration: biological function and detection methodology. Front Pharmacol 8:608. https:\/\/doi.org\/10.3389\/fphar.2017.00608","journal-title":"Front Pharmacol"},{"key":"4636_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9049782","volume":"2016","author":"S Panthi","year":"2016","unstructured":"Panthi S, Chung H-J, Jung J, Jeong NY (2016) Physiological importance of hydrogen sulfide: emerging potent neuroprotector and neuromodulator. Oxid Med Cell Longev 2016:1\u201311. https:\/\/doi.org\/10.1155\/2016\/9049782","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR139","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1152\/physrev.00017.2011","volume":"92","author":"R Wang","year":"2012","unstructured":"Wang R (2012) Physiological implications of hydrogen sulfide: a Whiff exploration that blossomed. Physiol Rev 92:791\u2013896. https:\/\/doi.org\/10.1152\/physrev.00017.2011","journal-title":"Physiol Rev"},{"key":"4636_CR140","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/biom11121899","volume":"11","author":"E Magli","year":"2021","unstructured":"Magli E, Perissutti E, Santagada V et al (2021) H2S donors and their use in medicinal chemistry. Biomolecules 11:1899. https:\/\/doi.org\/10.3390\/biom11121899","journal-title":"Biomolecules"},{"key":"4636_CR141","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/ars.2010.3671","volume":"15","author":"K Kida","year":"2011","unstructured":"Kida K, Yamada M, Tokuda K et al (2011) Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson\u2019s disease. Antioxid Redox Signal 15:343\u2013352. https:\/\/doi.org\/10.1089\/ars.2010.3671","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR142","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/ars.2012.5024","volume":"19","author":"R Xue","year":"2013","unstructured":"Xue R, Hao D-D, Sun J-P et al (2013) Hydrogen sulfide treatment promotes glucose uptake by increasing insulin receptor sensitivity and ameliorates kidney lesions in type 2 diabetes. Antioxid Redox Signal 19:5\u201323. https:\/\/doi.org\/10.1089\/ars.2012.5024","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR143","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","volume":"149","author":"CR Powell","year":"2018","unstructured":"Powell CR, Dillon KM, Matson JB (2018) A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications. Biochem Pharmacol 149:110\u2013123. https:\/\/doi.org\/10.1016\/j.bcp.2017.11.014","journal-title":"Biochem Pharmacol"},{"key":"4636_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.653601","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, Teng X, Hu Z et al (2021) Hydrogen sulfide attenuated sepsis-induced myocardial dysfunction through TLR4 pathway and endoplasmic reticulum stress. Front Physiol 12:653601. https:\/\/doi.org\/10.3389\/fphys.2021.653601","journal-title":"Front Physiol"},{"key":"4636_CR145","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jare.2020.06.005","volume":"27","author":"D Tian","year":"2021","unstructured":"Tian D, Teng X, Jin S et al (2021) Endogenous hydrogen sulfide improves vascular remodeling through PPAR\u03b4\/SOCS3 signaling. J Adv Res 27:115\u2013125. https:\/\/doi.org\/10.1016\/j.jare.2020.06.005","journal-title":"J Adv Res"},{"key":"4636_CR146","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.freeradbiomed.2009.09.018","volume":"47","author":"MN Hughes","year":"2009","unstructured":"Hughes MN, Centelles MN, Moore KP (2009) Making and working with hydrogen sulfide: the chemistry and generation of hydrogen sulfide in vitro and its measurement in vivo: a review. Free Radic Biol Med 47:1346\u20131353. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.09.018","journal-title":"Free Radic Biol Med"},{"key":"4636_CR147","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1021\/acs.jmedchem.5b00848","volume":"58","author":"W Feng","year":"2015","unstructured":"Feng W, Teo X-Y, Novera W et al (2015) Discovery of new H2S releasing phosphordithioates and 2,3-dihydro-2-phenyl-2-sulfanylenebenzo[d][1,3,2]oxazaphospholes with improved antiproliferative activity. J Med Chem 58:6456\u20136480. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00848","journal-title":"J Med Chem"},{"key":"4636_CR148","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","volume":"117","author":"L Li","year":"2008","unstructured":"Li L, Whiteman M, Guan YY et al (2008) Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 117:2351\u20132360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.753467","journal-title":"Circulation"},{"key":"4636_CR149","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3892\/mmr.2014.2901","volume":"11","author":"Z Wu","year":"2015","unstructured":"Wu Z, Peng H, Du Q et al (2015) GYY4137, a hydrogen sulfide-releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor-kappa B and mitogen-activated protein kinases in Coxsackie virus B3-infected rat cardiomyocytes. Mol Med Rep 11:1837\u20131844. https:\/\/doi.org\/10.3892\/mmr.2014.2901","journal-title":"Mol Med Rep"},{"key":"4636_CR150","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.3390\/ijms21124284","volume":"21","author":"LJ Ellmers","year":"2020","unstructured":"Ellmers LJ, Templeton EM, Pilbrow AP et al (2020) Hydrogen sulfide treatment improves post-infarct remodeling and long-term cardiac function in CSE knockout and wild-type mice. IJMS 21:4284. https:\/\/doi.org\/10.3390\/ijms21124284","journal-title":"IJMS"},{"key":"4636_CR151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021077","volume":"6","author":"ZW Lee","year":"2011","unstructured":"Lee ZW, Zhou J, Chen C-S et al (2011) The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE 6:e21077. https:\/\/doi.org\/10.1371\/journal.pone.0021077","journal-title":"PLoS ONE"},{"key":"4636_CR152","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.molimm.2021.12.003","volume":"141","author":"J Li","year":"2022","unstructured":"Li J, Li M, Li L et al (2022) Hydrogen sulfide attenuates ferroptosis and stimulates autophagy by blocking mTOR signaling in sepsis-induced acute lung injury. Mol Immunol 141:318\u2013327. https:\/\/doi.org\/10.1016\/j.molimm.2021.12.003","journal-title":"Mol Immunol"},{"key":"4636_CR153","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","volume":"45","author":"A Ahmad","year":"2016","unstructured":"Ahmad A, Olah G, Szczesny B et al (2016) AP39, a mitochondrially- targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock 45:88\u201397. https:\/\/doi.org\/10.1097\/SHK.0000000000000478","journal-title":"Shock"},{"key":"4636_CR154","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.niox.2014.04.008","volume":"41","author":"B Szczesny","year":"2014","unstructured":"Szczesny B, M\u00f3dis K, Yanagi K et al (2014) AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide 41:120\u2013130. https:\/\/doi.org\/10.1016\/j.niox.2014.04.008","journal-title":"Nitric Oxide"},{"key":"4636_CR155","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.niox.2015.05.001","volume":"49","author":"K Ikeda","year":"2015","unstructured":"Ikeda K, Marutani E, Hirai S et al (2015) Mitochondria-targeted hydrogen sulfide donor AP39 improves neurological outcomes after cardiac arrest in mice. Nitric Oxide 49:90\u201396. https:\/\/doi.org\/10.1016\/j.niox.2015.05.001","journal-title":"Nitric Oxide"},{"key":"4636_CR156","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bph.13688","volume":"174","author":"QG Karwi","year":"2017","unstructured":"Karwi QG, Bornbaum J, Boengler K et al (2017) AP39, a mitochondria-targeting hydrogen sulfide (H2S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling. Br J Pharmacol 174:287\u2013301. https:\/\/doi.org\/10.1111\/bph.13688","journal-title":"Br J Pharmacol"},{"key":"4636_CR157","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/bph.14641","volume":"177","author":"JL Wallace","year":"2020","unstructured":"Wallace JL, Nagy P, Feener TD et al (2020) A proof-of-concept, phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug. Br J Pharmacol 177:769\u2013777. https:\/\/doi.org\/10.1111\/bph.14641","journal-title":"Br J Pharmacol"},{"key":"4636_CR158","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.niox.2014.11.010","volume":"46","author":"B Gemici","year":"2015","unstructured":"Gemici B, Elsheikh W, Feitosa KB et al (2015) H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential. Nitric Oxide 46:25\u201331. https:\/\/doi.org\/10.1016\/j.niox.2014.11.010","journal-title":"Nitric Oxide"},{"key":"4636_CR159","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/ars.2019.7884","volume":"33","author":"SKPF Costa","year":"2020","unstructured":"Costa SKPF, Muscara MN, Allain T et al (2020) Enhanced analgesic effects and gastrointestinal safety of a novel, hydrogen sulfide-releasing anti-inflammatory drug (ATB-352): a role for endogenous cannabinoids. Antioxid Redox Signal 33:1003\u20131009. https:\/\/doi.org\/10.1089\/ars.2019.7884","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR160","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1755-5922.12128","volume":"33","author":"DJ Polhemus","year":"2015","unstructured":"Polhemus DJ, Li Z, Pattillo CB et al (2015) A novel hydrogen sulfide prodrug, SG 1002, promotes hydrogen sulfide and nitric oxide bioavailability in heart failure patients. Cardiovasc Ther 33:216\u2013226. https:\/\/doi.org\/10.1111\/1755-5922.12128","journal-title":"Cardiovasc Ther"},{"key":"4636_CR161","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1039\/D1CC01309B","volume":"57","author":"K Kaur","year":"2021","unstructured":"Kaur K, Enders P, Zhu Y et al (2021) Amino acid-based H2S donors: N-thiocarboxyanhydrides that release H2S with innocuous byproducts. Chem Commun 57:5522\u20135525. https:\/\/doi.org\/10.1039\/D1CC01309B","journal-title":"Chem Commun"},{"key":"4636_CR162","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/ars.2019.7841","volume":"32","author":"CM Levinn","year":"2020","unstructured":"Levinn CM, Cerda MM, Pluth MD (2020) Activatable small-molecule hydrogen sulfide donors. Antioxid Redox Signal 32:96\u2013109. https:\/\/doi.org\/10.1089\/ars.2019.7841","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR163","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3390\/antiox10030429","volume":"10","author":"A Corvino","year":"2021","unstructured":"Corvino A, Frecentese F, Magli E et al (2021) Trends in H2S-donors chemistry and their effects in cardiovascular diseases. Antioxidants (Basel) 10:429. https:\/\/doi.org\/10.3390\/antiox10030429","journal-title":"Antioxidants (Basel)"},{"key":"4636_CR164","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1073\/pnas.0705710104","volume":"104","author":"GA Benavides","year":"2007","unstructured":"Benavides GA, Squadrito GL, Mills RW et al (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104:17977\u201317982. https:\/\/doi.org\/10.1073\/pnas.0705710104","journal-title":"Proc Natl Acad Sci USA"},{"key":"4636_CR165","doi-asserted-by":"publisher","first-page":"C41","DOI":"10.1152\/ajpcell.00398.2011","volume":"303","author":"U Sen","year":"2012","unstructured":"Sen U, Sathnur PB, Kundu S et al (2012) Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 303:C41\u2013C51. https:\/\/doi.org\/10.1152\/ajpcell.00398.2011","journal-title":"Am J Physiol Cell Physiol"},{"key":"4636_CR166","doi-asserted-by":"publisher","unstructured":"Shaposhnikov M, Proshkina E, Koval L et al (2018) Overexpression of CBS and CSE genes affects lifespan, stress resistance and locomotor activity in Drosophila melanogaster. Aging (Albany NY) 10:3260\u20133272. https:\/\/doi.org\/10.18632\/aging.101630","DOI":"10.18632\/aging.101630"},{"key":"4636_CR167","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1007\/s12035-018-1323-2","volume":"56","author":"J London","year":"2019","unstructured":"London J, Ndiaye FK, Bui LC et al (2019) Alterations in the serotonin and dopamine pathways by cystathionine beta synthase overexpression in murine brain. Mol Neurobiol 56:3958\u20133971. https:\/\/doi.org\/10.1007\/s12035-018-1323-2","journal-title":"Mol Neurobiol"},{"key":"4636_CR168","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/hmg\/ddy447","volume":"28","author":"D Marechal","year":"2019","unstructured":"Marechal D, Brault V, Leon A et al (2019) Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1a. Hum Mol Genet 28:1561\u20131577. https:\/\/doi.org\/10.1093\/hmg\/ddy447","journal-title":"Hum Mol Genet"},{"key":"4636_CR169","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nrd2425","volume":"6","author":"C Szab\u00f3","year":"2007","unstructured":"Szab\u00f3 C (2007) Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6:917\u2013935. https:\/\/doi.org\/10.1038\/nrd2425","journal-title":"Nat Rev Drug Discov"},{"key":"4636_CR170","doi-asserted-by":"publisher","first-page":"C3","DOI":"10.1152\/ajpcell.00282.2016","volume":"312","author":"C Szabo","year":"2017","unstructured":"Szabo C (2017) Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications. Am J Physiol, Cell Physiol 312:C3\u2013C15. https:\/\/doi.org\/10.1152\/ajpcell.00282.2016","journal-title":"Am J Physiol, Cell Physiol"},{"key":"4636_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2008.2282","volume":"12","author":"Y Kimura","year":"2010","unstructured":"Kimura Y, Goto Y-I, Kimura H (2010) Hydrogen sulfide increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 12:1\u201313. https:\/\/doi.org\/10.1089\/ars.2008.2282","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR172","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1021\/tx100266a","volume":"23","author":"P Nagy","year":"2010","unstructured":"Nagy P, Winterbourn CC (2010) Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides. Chem Res Toxicol 23:1541\u20131543. https:\/\/doi.org\/10.1021\/tx100266a","journal-title":"Chem Res Toxicol"},{"key":"4636_CR173","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/antiox7100129","volume":"7","author":"T Corsello","year":"2018","unstructured":"Corsello T, Komaravelli N, Casola A (2018) Role of hydrogen sulfide in NRF2- and sirtuin-dependent maintenance of cellular redox balance. Antioxidants 7:129. https:\/\/doi.org\/10.3390\/antiox7100129","journal-title":"Antioxidants"},{"key":"4636_CR174","doi-asserted-by":"publisher","unstructured":"Eleftheriadis T, Pissas G, Nikolaou E et al (2020) Mistimed H2S upregulation, Nrf2 activation and antioxidant proteins levels in renal tubular epithelial cells subjected to anoxia and reoxygenation. Biom Rep. https:\/\/doi.org\/10.3892\/br.2020.1309","DOI":"10.3892\/br.2020.1309"},{"key":"4636_CR175","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1089\/ars.2012.4645","volume":"18","author":"G Yang","year":"2013","unstructured":"Yang G, Zhao K, Ju Y et al (2013) Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 18:1906\u20131919. https:\/\/doi.org\/10.1089\/ars.2012.4645","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR176","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/ars.2012.4944","volume":"19","author":"JM Hourihan","year":"2013","unstructured":"Hourihan JM, Kenna JG, Hayes JD (2013) The gasotransmitter hydrogen sulfide induces Nrf2-target genes by inactivating the Keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between Cys-226 and Cys-613. Antioxid Redox Signal 19:465\u2013481. https:\/\/doi.org\/10.1089\/ars.2012.4944","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR177","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.freeradbiomed.2015.06.021","volume":"88","author":"LE Tebay","year":"2015","unstructured":"Tebay LE, Robertson H, Durant ST et al (2015) Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med 88:108\u2013146. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.06.021","journal-title":"Free Radic Biol Med"},{"key":"4636_CR178","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1161\/CIRCULATIONAHA.107.698316","volume":"117","author":"J Dulak","year":"2008","unstructured":"Dulak J, Deshane J, Jozkowicz A, Agarwal A (2008) Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation 117:231\u2013241. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.698316","journal-title":"Circulation"},{"key":"4636_CR179","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1089\/ars.2008.2043","volume":"10","author":"A Loboda","year":"2008","unstructured":"Loboda A, Jazwa A, Grochot-Przeczek A et al (2008) Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10:1767\u20131812. https:\/\/doi.org\/10.1089\/ars.2008.2043","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR180","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E et al (2016) Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci 73:3221\u20133247. https:\/\/doi.org\/10.1007\/s00018-016-2223-0","journal-title":"Cell Mol Life Sci"},{"key":"4636_CR181","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/ars.2011.3964","volume":"16","author":"M Kozakowska","year":"2012","unstructured":"Kozakowska M, Ciesla M, Stefanska A et al (2012) Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16:113\u2013127. https:\/\/doi.org\/10.1089\/ars.2011.3964","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR182","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ajpath.2017.10.017","volume":"188","author":"M Kozakowska","year":"2018","unstructured":"Kozakowska M, Pietraszek-Gremplewicz K, Ciesla M et al (2018) Lack of heme oxygenase-1 induces inflammatory reaction and proliferation of muscle satellite cells after cardiotoxin-induced skeletal muscle injury. Am J Pathol 188:491\u2013506. https:\/\/doi.org\/10.1016\/j.ajpath.2017.10.017","journal-title":"Am J Pathol"},{"key":"4636_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109018","volume":"35","author":"RW Alves de Souza","year":"2021","unstructured":"Alves de Souza RW, Gallo D, Lee GR et al (2021) Skeletal muscle heme oxygenase-1 activity regulates aerobic capacity. Cell Rep 35:109018. https:\/\/doi.org\/10.1016\/j.celrep.2021.109018","journal-title":"Cell Rep"},{"key":"4636_CR184","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/ars.2017.7435","volume":"29","author":"K Pietraszek-Gremplewicz","year":"2018","unstructured":"Pietraszek-Gremplewicz K, Kozakowska M, Bronisz-Budzynska I et al (2018) Heme oxygenase-1 influences satellite cells and progression of duchenne muscular dystrophy in mice. Antioxid Redox Signal 29:128\u2013148. https:\/\/doi.org\/10.1089\/ars.2017.7435","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR185","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013065","volume":"97","author":"Q Xiao","year":"2018","unstructured":"Xiao Q, Ying J, Xiang L, Zhang C (2018) The biologic effect of hydrogen sulfide and its function in various diseases. Medicine 97:e13065. https:\/\/doi.org\/10.1097\/MD.0000000000013065","journal-title":"Medicine"},{"key":"4636_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118630","volume":"264","author":"S Waz","year":"2021","unstructured":"Waz S, Heeba GH, Hassanin SO, Abdel-Latif RG (2021) Nephroprotective effect of exogenous hydrogen sulfide donor against cyclophosphamide-induced toxicity is mediated by Nrf2\/HO-1\/NF-\u03baB signaling pathway. Life Sci 264:118630. https:\/\/doi.org\/10.1016\/j.lfs.2020.118630","journal-title":"Life Sci"},{"key":"4636_CR187","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3892\/br.2013.87","volume":"1","author":"C-Y Zhang","year":"2013","unstructured":"Zhang C-Y, Li X-H, Zhang T et al (2013) Hydrogen sulfide upregulates heme oxygenase-1 expression in rats with volume overload-induced heart failure. Biomed Rep 1:454\u2013458. https:\/\/doi.org\/10.3892\/br.2013.87","journal-title":"Biomed Rep"},{"key":"4636_CR188","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.lfs.2013.10.007","volume":"93","author":"W Hua","year":"2013","unstructured":"Hua W, Chen Q, Gong F et al (2013) Cardioprotection of H2S by downregulating iNOS and upregulating HO-1 expression in mice with CVB3-induced myocarditis. Life Sci 93:949\u2013954. https:\/\/doi.org\/10.1016\/j.lfs.2013.10.007","journal-title":"Life Sci"},{"key":"4636_CR189","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCRESAHA.109.199919","volume":"105","author":"JW Calvert","year":"2009","unstructured":"Calvert JW, Jha S, Gundewar S et al (2009) Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105:365\u2013374. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.199919","journal-title":"Circ Res"},{"key":"4636_CR190","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbrc.2004.02.176","volume":"317","author":"Z Qingyou","year":"2004","unstructured":"Qingyou Z, Junbao D, Weijin Z et al (2004) Impact of hydrogen sulfide on carbon monoxide\/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension. Biochem Biophys Res Commun 317:30\u201337. https:\/\/doi.org\/10.1016\/j.bbrc.2004.02.176","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR191","first-page":"5097","volume":"8","author":"G Wang","year":"2015","unstructured":"Wang G, Li W, Chen Q et al (2015) Hydrogen sulfide accelerates wound healing in diabetic rats. Int J Clin Exp Pathol 8:5097\u20135104","journal-title":"Int J Clin Exp Pathol"},{"key":"4636_CR192","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2014.0022","volume":"12","author":"SK Jain","year":"2014","unstructured":"Jain SK, Huning L, Micinski D (2014) Hydrogen sulfide upregulates glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, and glutathione and inhibits interleukin-1\u03b2 secretion in monocytes exposed to high glucose levels. Metab Syndr Relat Disord 12:299\u2013302. https:\/\/doi.org\/10.1089\/met.2014.0022","journal-title":"Metab Syndr Relat Disord"},{"key":"4636_CR193","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.redox.2017.04.031","volume":"12","author":"X Chen","year":"2017","unstructured":"Chen X, Zhao X, Cai H et al (2017) The role of sodium hydrosulfide in attenuating the aging process via PI3K\/AKT and CaMKK\u03b2\/AMPK pathways. Redox Biol 12:987\u20131003. https:\/\/doi.org\/10.1016\/j.redox.2017.04.031","journal-title":"Redox Biol"},{"key":"4636_CR194","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbrc.2014.10.033","volume":"454","author":"M Yang","year":"2014","unstructured":"Yang M, Huang Y, Chen J et al (2014) Activation of AMPK participates hydrogen sulfide-induced cyto-protective effect against dexamethasone in osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 454:42\u201347. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.033","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR195","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/ars.2010.3190","volume":"14","author":"CY Han","year":"2011","unstructured":"Han CY, Ki SH, Kim YW et al (2011) Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxid Redox Signal 14:187\u2013202. https:\/\/doi.org\/10.1089\/ars.2010.3190","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR196","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1089\/ars.2010.3147","volume":"13","author":"M Gertz","year":"2010","unstructured":"Gertz M, Steegborn C (2010) The lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor? Antioxid Redox Signal 13:1417\u20131428. https:\/\/doi.org\/10.1089\/ars.2010.3147","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/193095","volume":"2014","author":"A Magenta","year":"2014","unstructured":"Magenta A, Greco S, Capogrossi MC et al (2014) Nitric oxide, oxidative stress, and p 66 S h c interplay in diabetic endothelial dysfunction. Biomed Res Int 2014:1\u201316. https:\/\/doi.org\/10.1155\/2014\/193095","journal-title":"Biomed Res Int"},{"key":"4636_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4814696","volume":"2018","author":"M D\u2019Agostino","year":"2018","unstructured":"D\u2019Agostino M, Torcinaro A, Madaro L et al (2018) Role of miR-200c in myogenic differentiation impairment via p66Shc: implication in skeletal muscle regeneration of dystrophic mdx mice. Oxid Med Cell Longev 2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/4814696","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR199","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1089\/ars.2013.5604","volume":"21","author":"Z-Z Xie","year":"2014","unstructured":"Xie Z-Z, Shi M-M, Xie L et al (2014) Sulfhydration of p66Shc at cysteine59 mediates the antioxidant effect of hydrogen sulfide. Antioxid Redox Signal 21:2531\u20132542. https:\/\/doi.org\/10.1089\/ars.2013.5604","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR200","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tcm.2013.01.001","volume":"23","author":"H-Z Chen","year":"2013","unstructured":"Chen H-Z, Wan Y-Z, Liu D-P (2013) Cross-talk between SIRT1 and p66Shc in vascular diseases. Trends Cardiovasc Med 23:237\u2013241. https:\/\/doi.org\/10.1016\/j.tcm.2013.01.001","journal-title":"Trends Cardiovasc Med"},{"key":"4636_CR201","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1096\/fj.201600410RR","volume":"30","author":"M Buler","year":"2016","unstructured":"Buler M, Andersson U, Hakkola J (2016) Who watches the watchmen? Regulation of the expression and activity of sirtuins. FASEB j 30:3942\u20133960. https:\/\/doi.org\/10.1096\/fj.201600410RR","journal-title":"FASEB j"},{"key":"4636_CR202","doi-asserted-by":"publisher","first-page":"6714686","DOI":"10.1155\/2016\/6714686","volume":"2016","author":"A Kuno","year":"2016","unstructured":"Kuno A, Horio Y (2016) SIRT1: a novel target for the treatment of muscular dystrophies. Oxid Med Cell Longev 2016:6714686. https:\/\/doi.org\/10.1155\/2016\/6714686","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR203","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1089\/ars.2017.7195","volume":"30","author":"C Du","year":"2019","unstructured":"Du C, Lin X, Xu W et al (2019) Sulfhydrated sirtuin-1 increasing its deacetylation activity is an essential epigenetics mechanism of anti-atherogenesis by hydrogen sulfide. Antioxid Redox Signal 30:184\u2013197. https:\/\/doi.org\/10.1089\/ars.2017.7195","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR204","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089856","volume":"9","author":"X Li","year":"2014","unstructured":"Li X, Zhang K-Y, Zhang P et al (2014) Hydrogen sulfide inhibits formaldehyde-induced endoplasmic reticulum stress in PC12 cells by upregulation of SIRT-1. PLoS ONE 9:e89856. https:\/\/doi.org\/10.1371\/journal.pone.0089856","journal-title":"PLoS ONE"},{"key":"4636_CR205","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3892\/mmr.2013.1417","volume":"7","author":"R Suo","year":"2013","unstructured":"Suo R, Zhao Z-Z, Tang Z-H et al (2013) Hydrogen sulfide prevents H2O2-induced senescence in human umbilical vein endothelial cells through SIRT1 activation. Mol Med Rep 7:1865\u20131870. https:\/\/doi.org\/10.3892\/mmr.2013.1417","journal-title":"Mol Med Rep"},{"key":"4636_CR206","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bbrc.2003.11.130","volume":"313","author":"B Geng","year":"2004","unstructured":"Geng B, Yang J, Qi Y et al (2004) H2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 313:362\u2013368. https:\/\/doi.org\/10.1016\/j.bbrc.2003.11.130","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR207","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1124\/jpet.105.092023","volume":"316","author":"J-S Bian","year":"2006","unstructured":"Bian J-S, Yong QC, Pan T-T et al (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316:670\u2013678. https:\/\/doi.org\/10.1124\/jpet.105.092023","journal-title":"J Pharmacol Exp Ther"},{"key":"4636_CR208","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/CIRCULATIONAHA.108.833491","volume":"120","author":"S Minamishima","year":"2009","unstructured":"Minamishima S, Bougaki M, Sips PY et al (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3 dependent mechanism in mice. Circulation 120:888\u2013896. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.833491","journal-title":"Circulation"},{"key":"4636_CR209","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.bbrc.2015.02.017","volume":"458","author":"H Xie","year":"2015","unstructured":"Xie H, Xu Q, Jia J et al (2015) Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux. Biochem Biophys Res Commun 458:632\u2013638. https:\/\/doi.org\/10.1016\/j.bbrc.2015.02.017","journal-title":"Biochem Biophys Res Commun"},{"key":"4636_CR210","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/s10495-014-0978-z","volume":"19","author":"X Zhou","year":"2014","unstructured":"Zhou X, An G, Chen J (2014) Hydrogen sulfide improves left ventricular function in smoking rats via regulation of apoptosis and autophagy. Apoptosis 19:998\u20131005. https:\/\/doi.org\/10.1007\/s10495-014-0978-z","journal-title":"Apoptosis"},{"key":"4636_CR211","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.niox.2014.12.013","volume":"46","author":"LA Barr","year":"2015","unstructured":"Barr LA, Shimizu Y, Lambert JP et al (2015) Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide 46:145\u2013156. https:\/\/doi.org\/10.1016\/j.niox.2014.12.013","journal-title":"Nitric Oxide"},{"key":"4636_CR212","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1517\/13543776.2011.553601","volume":"21","author":"S Rapposelli","year":"2011","unstructured":"Rapposelli S (2011) Novel adenosine 5\u2032-triphosphate-sensitive potassium channel ligands: a patent overview (2005\u20132010). Expert Opin Ther Pat 21:355\u2013379. https:\/\/doi.org\/10.1517\/13543776.2011.553601","journal-title":"Expert Opin Ther Pat"},{"key":"4636_CR213","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exer.2016.04.020","volume":"158","author":"U Roy Chowdhury","year":"2017","unstructured":"Roy Chowdhury U, Dosa PI, Fautsch MP (2017) ATP sensitive potassium channel openers: a new class of ocular hypotensive agents. Exp Eye Res 158:85\u201393. https:\/\/doi.org\/10.1016\/j.exer.2016.04.020","journal-title":"Exp Eye Res"},{"key":"4636_CR214","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3892\/mmr.2015.4714","volume":"13","author":"Z Liu","year":"2016","unstructured":"Liu Z, Cai H, Dang Y et al (2016) Adenosine triphosphate-sensitive potassium channels and cardiomyopathies (Review). Mol Med Rep 13:1447\u20131454. https:\/\/doi.org\/10.3892\/mmr.2015.4714","journal-title":"Mol Med Rep"},{"key":"4636_CR215","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1476-5381.2010.01072.x","volume":"162","author":"OI Voitychuk","year":"2011","unstructured":"Voitychuk OI, Strutynskyi RB, Yagupolskii LM et al (2011) Sarcolemmal cardiac KATP channels as a target for the cardioprotective effects of the fluorine-containing pinacidil analogue, flocalin: cardioprotective effects of flocalin. Br J Pharmacol 162:701\u2013711. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01072.x","journal-title":"Br J Pharmacol"},{"key":"4636_CR216","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00613809","volume":"24","author":"A McNair","year":"1983","unstructured":"McNair A, Andreasen F, Nielsen PE (1983) Antihypertensive effect of diazoxide given intravenously in small repeated doses. Eur J Clin Pharmacol 24:151\u2013156. https:\/\/doi.org\/10.1007\/BF00613809","journal-title":"Eur J Clin Pharmacol"},{"key":"4636_CR217","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yjmcc.2005.04.006","volume":"39","author":"A Jahangir","year":"2005","unstructured":"Jahangir A, Terzic A (2005) K channel therapeutics at the bedside. J Mol Cell Cardiol 39:99\u2013112. https:\/\/doi.org\/10.1016\/j.yjmcc.2005.04.006","journal-title":"J Mol Cell Cardiol"},{"key":"4636_CR218","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/ng1329","volume":"36","author":"M Bienengraeber","year":"2004","unstructured":"Bienengraeber M, Olson TM, Selivanov VA et al (2004) ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 36:382\u2013387. https:\/\/doi.org\/10.1038\/ng1329","journal-title":"Nat Genet"},{"key":"4636_CR219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027034","volume":"6","author":"L Graciotti","year":"2011","unstructured":"Graciotti L, Becker J, Granata AL et al (2011) Dystrophin is required for the normal function of the cardio-protective KATP channel in cardiomyocytes. PLoS ONE 6:e27034. https:\/\/doi.org\/10.1371\/journal.pone.0027034","journal-title":"PLoS ONE"},{"key":"4636_CR220","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1093\/emboj\/cdg192","volume":"22","author":"DM Hodgson","year":"2003","unstructured":"Hodgson DM (2003) Cellular remodeling in heart failure disrupts KATP channel-dependent stress tolerance. EMBO J 22:1732\u20131742. https:\/\/doi.org\/10.1093\/emboj\/cdg192","journal-title":"EMBO J"},{"key":"4636_CR221","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/ars.2009.2894","volume":"12","author":"B Jiang","year":"2010","unstructured":"Jiang B, Tang G, Cao K et al (2010) Molecular mechanism for H2S-induced activation of KATP channels. Antioxid Redox Signal 12:1167\u20131178. https:\/\/doi.org\/10.1089\/ars.2009.2894","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR222","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1124\/mol.112.081596","volume":"83","author":"AR Gade","year":"2013","unstructured":"Gade AR, Kang M, Akbarali HI (2013) Hydrogen sulfide as an allosteric modulator of ATP-sensitive potassium channels in colonic inflammation. Mol Pharmacol 83:294\u2013306. https:\/\/doi.org\/10.1124\/mol.112.081596","journal-title":"Mol Pharmacol"},{"key":"4636_CR223","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13683","author":"L Mys","year":"2022","unstructured":"Mys L, Goshovska Y, Strutynska N et al (2022) Pyridoxal-5-phosphate induced cardioprotection in aging associated with up-expression of cystathionine-\u03b3-lyase, 3-mercaptopyruvate sulfurtransferase, and ATP-sensitive potassium channels. Eur J Clin Investig. https:\/\/doi.org\/10.1111\/eci.13683","journal-title":"Eur J Clin Investig"},{"key":"4636_CR224","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3892\/ijmm.2016.2467","volume":"37","author":"W Liang","year":"2016","unstructured":"Liang W, Chen J, Mo L et al (2016) ATP-sensitive K+ channels contribute to the protective effects of exogenous hydrogen sulfide against high glucose-induced injury in H9c2 cardiac cells. Int J Mol Med 37:763\u2013772. https:\/\/doi.org\/10.3892\/ijmm.2016.2467","journal-title":"Int J Mol Med"},{"key":"4636_CR225","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.phrs.2016.09.006","volume":"113","author":"L Testai","year":"2016","unstructured":"Testai L, Marino A, Piano I et al (2016) The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia\/reperfusion injury through activation of mitoK ATP channels and reduction of oxidative stress. Pharmacol Res 113:290\u2013299. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.006","journal-title":"Pharmacol Res"},{"key":"4636_CR226","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","volume":"9","author":"M Fioranelli","year":"2018","unstructured":"Fioranelli M, Bottaccioli AG, Bottaccioli F et al (2018) Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol 9:2031. https:\/\/doi.org\/10.3389\/fimmu.2018.02031","journal-title":"Front Immunol"},{"key":"4636_CR227","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-017-1206-8","volume":"15","author":"F Benedetti","year":"2017","unstructured":"Benedetti F, Curreli S, Krishnan S et al (2017) Anti-inflammatory effects of H2S during acute bacterial infection: a review. J Transl Med 15:100. https:\/\/doi.org\/10.1186\/s12967-017-1206-8","journal-title":"J Transl Med"},{"key":"4636_CR228","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.taap.2017.11.004","volume":"338","author":"C Bourque","year":"2018","unstructured":"Bourque C, Zhang Y, Fu M et al (2018) H2S protects lipopolysaccharide-induced inflammation by blocking NF\u03baB transactivation in endothelial cells. Toxicol Appl Pharmacol 338:20\u201329. https:\/\/doi.org\/10.1016\/j.taap.2017.11.004","journal-title":"Toxicol Appl Pharmacol"},{"key":"4636_CR229","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41467-018-05910-1","volume":"9","author":"JM Peterson","year":"2018","unstructured":"Peterson JM, Wang DJ, Shettigar V et al (2018) NF-\u03baB inhibition rescues cardiac function by remodeling calcium genes in a Duchenne muscular dystrophy model. Nat Commun 9:3431. https:\/\/doi.org\/10.1038\/s41467-018-05910-1","journal-title":"Nat Commun"},{"key":"4636_CR230","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1038\/srep04774","volume":"4","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Li H, Zhao G et al (2015) Hydrogen sulfide attenuates the recruitment of CD11b+Gr-1+ myeloid cells and regulates Bax\/Bcl-2 signaling in myocardial ischemia injury. Sci Rep 4:4774. https:\/\/doi.org\/10.1038\/srep04774","journal-title":"Sci Rep"},{"key":"4636_CR231","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1089\/ars.2011.4363","volume":"17","author":"K Tokuda","year":"2012","unstructured":"Tokuda K, Kida K, Marutani E et al (2012) Inhaled hydrogen sulfide prevents endotoxin-induced systemic inflammation and improves survival by altering sulfide metabolism in mice. Antioxid Redox Signal 17:11\u201321. https:\/\/doi.org\/10.1089\/ars.2011.4363","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR232","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1089\/ars.2013.5587","volume":"21","author":"X Zhou","year":"2014","unstructured":"Zhou X, Cao Y, Ao G et al (2014) CaMKK\u03b2-dependent activation of AMP-activated protein kinase is critical to suppressive effects of hydrogen sulfide on neuroinflammation. Antioxid Redox Signal 21:1741\u20131758. https:\/\/doi.org\/10.1089\/ars.2013.5587","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR233","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.freeradbiomed.2017.08.017","volume":"112","author":"SJ Han","year":"2017","unstructured":"Han SJ, Noh MR, Jung J-M et al (2017) Hydrogen sulfide-producing cystathionine \u03b3-lyase is critical in the progression of kidney fibrosis. Free Radic Biol Med 112:423\u2013432. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.08.017","journal-title":"Free Radic Biol Med"},{"key":"4636_CR234","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1097\/CM9.0000000000000537","volume":"132","author":"Y Wang","year":"2019","unstructured":"Wang Y, Xing Q-Q, Tu J-K et al (2019) Involvement of hydrogen sulfide in the progression of renal fibrosis. Chin Med J (Engl) 132:2872\u20132880. https:\/\/doi.org\/10.1097\/CM9.0000000000000537","journal-title":"Chin Med J (Engl)"},{"key":"4636_CR235","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.2147\/IJN.S216667","volume":"14","author":"BH Tran","year":"2019","unstructured":"Tran BH, Yu Y, Chang L et al (2019) A novel liposomal S-propargyl-cysteine: a sustained release of hydrogen sulfide reducing myocardial fibrosis via TGF-\u03b21\/Smad pathway. Int J Nanomed 14:10061\u201310077. https:\/\/doi.org\/10.2147\/IJN.S216667","journal-title":"Int J Nanomed"},{"key":"4636_CR236","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/691070","volume":"2015","author":"G Meng","year":"2015","unstructured":"Meng G, Zhu J, Xiao Y et al (2015) Hydrogen sulfide donor GYY4137 protects against myocardial fibrosis. Oxid Med Cell Longev 2015:691070. https:\/\/doi.org\/10.1155\/2015\/691070","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR237","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.05.026","volume":"76","author":"W-J Cai","year":"2007","unstructured":"Cai W-J, Wang M-J, Moore PK et al (2007) The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 76:29\u201340. https:\/\/doi.org\/10.1016\/j.cardiores.2007.05.026","journal-title":"Cardiovasc Res"},{"key":"4636_CR238","doi-asserted-by":"publisher","first-page":"21972","DOI":"10.1073\/pnas.0908047106","volume":"106","author":"A Papapetropoulos","year":"2009","unstructured":"Papapetropoulos A, Pyriochou A, Altaany Z et al (2009) Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci USA 106:21972\u201321977. https:\/\/doi.org\/10.1073\/pnas.0908047106","journal-title":"Proc Natl Acad Sci USA"},{"key":"4636_CR239","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2021.0105","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li X, Xue W-L et al (2022) YB-1 recruits Drosha to promote splicing of pri-miR-192 to mediate the proangiogenic effects of H2S. Antioxid Redox Signal. https:\/\/doi.org\/10.1089\/ars.2021.0105","journal-title":"Antioxid Redox Signal"},{"key":"4636_CR240","doi-asserted-by":"publisher","first-page":"C857","DOI":"10.1152\/ajpcell.00406.2019","volume":"318","author":"W-L Xue","year":"2020","unstructured":"Xue W-L, Chen R-Q, Zhang Q-Q et al (2020) Hydrogen sulfide rescues high glucose-induced migration dysfunction in HUVECs by upregulating miR-126-3p. Am J Physiol Cell Physiol 318:C857\u2013C869. https:\/\/doi.org\/10.1152\/ajpcell.00406.2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"4636_CR241","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1096\/fj.09-143651","volume":"24","author":"NC Chen","year":"2010","unstructured":"Chen NC, Yang F, Capecci LM et al (2010) Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 24:2804\u20132817. https:\/\/doi.org\/10.1096\/fj.09-143651","journal-title":"FASEB J"},{"key":"4636_CR242","doi-asserted-by":"publisher","first-page":"9362","DOI":"10.1111\/jcmm.15587","volume":"24","author":"F Lu","year":"2020","unstructured":"Lu F, Lu B, Zhang L et al (2020) Hydrogen sulphide ameliorating skeletal muscle atrophy in db\/db mice via Muscle RING finger 1 S-sulfhydration. J Cell Mol Med 24:9362\u20139377. https:\/\/doi.org\/10.1111\/jcmm.15587","journal-title":"J Cell Mol Med"},{"key":"4636_CR243","doi-asserted-by":"publisher","unstructured":"Ellwood RA, Hewitt JE, Torregrossa R et al (2021) Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model. Proc Natl Acad Sci USA 118:e2018342118. https:\/\/doi.org\/10.1073\/pnas.2018342118","DOI":"10.1073\/pnas.2018342118"},{"key":"4636_CR244","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.niox.2014.11.012","volume":"46","author":"S Veeranki","year":"2015","unstructured":"Veeranki S, Tyagi SC (2015) Role of hydrogen sulfide in skeletal muscle biology and metabolism. Nitric Oxide 46:66\u201371. https:\/\/doi.org\/10.1016\/j.niox.2014.11.012","journal-title":"Nitric Oxide"},{"key":"4636_CR245","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202002675R","volume":"35","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Masters L, Wang Y et al (2021) Cystathionine gamma-lyase\/H2S signaling facilitates myogenesis under aging and injury condition. FASEB J 35:e21511. https:\/\/doi.org\/10.1096\/fj.202002675R","journal-title":"FASEB J"},{"key":"4636_CR246","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3760\/cma.j.issn.0366-6999.20122485","volume":"126","author":"J Du","year":"2013","unstructured":"Du J, Li W, Yang J et al (2013) Hydrogen sulfide is endogenously generated in rat skeletal muscle and exerts a protective effect against oxidative stress. Chin Med J (Engl) 126:930\u2013936","journal-title":"Chin Med J (Engl)"},{"key":"4636_CR247","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001986","volume":"4","author":"KN Islam","year":"2015","unstructured":"Islam KN, Polhemus DJ, Donnarumma E et al (2015) Hydrogen sulfide levels and nuclear factor-erythroid 2-related factor 2 (NRF2) activity are attenuated in the setting of critical limb ischemia (CLI). J Am Heart Assoc 4:e001986. https:\/\/doi.org\/10.1161\/JAHA.115.001986","journal-title":"J Am Heart Assoc"},{"key":"4636_CR248","doi-asserted-by":"publisher","first-page":"6825452","DOI":"10.1155\/2018\/6825452","volume":"2018","author":"MS Bitar","year":"2018","unstructured":"Bitar MS, Nader J, Al-Ali W et al (2018) Hydrogen sulfide donor NaHS improves metabolism and reduces muscle atrophy in type 2 diabetes: implication for understanding sarcopenic pathophysiology. Oxid Med Cell Longev 2018:6825452. https:\/\/doi.org\/10.1155\/2018\/6825452","journal-title":"Oxid Med Cell Longev"},{"key":"4636_CR249","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1203\/00006450-197606000-00008","volume":"10","author":"YS Kanwar","year":"1976","unstructured":"Kanwar YS, Manaligod JR, Wong PW (1976) Morphologic studies in a patient with homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency. Pediatr Res 10:598\u2013609. https:\/\/doi.org\/10.1203\/00006450-197606000-00008","journal-title":"Pediatr Res"},{"key":"4636_CR250","doi-asserted-by":"publisher","first-page":"26358","DOI":"10.1074\/jbc.M110.147439","volume":"285","author":"I Ishii","year":"2010","unstructured":"Ishii I, Akahoshi N, Yamada H et al (2010) Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. J Biol Chem 285:26358\u201326368. https:\/\/doi.org\/10.1074\/jbc.M110.147439","journal-title":"J Biol Chem"},{"key":"4636_CR251","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/10715762.2018.1431626","volume":"52","author":"R Parsanathan","year":"2018","unstructured":"Parsanathan R, Jain SK (2018) Hydrogen sulfide increases glutathione biosynthesis, and glucose uptake and utilisation in C2C12 mouse myotubes. Free Radic Res 52:288\u2013303. https:\/\/doi.org\/10.1080\/10715762.2018.1431626","journal-title":"Free Radic Res"},{"key":"4636_CR252","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.533690","volume":"11","author":"L Zhao","year":"2020","unstructured":"Zhao L, Liu X, Zhang J et al (2020) Hydrogen sulfide alleviates skeletal muscle fibrosis via attenuating inflammation and oxidative stress. Front Physiol 11:533690. https:\/\/doi.org\/10.3389\/fphys.2020.533690","journal-title":"Front Physiol"},{"key":"4636_CR253","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1177\/1535370220931038","volume":"245","author":"R Yang","year":"2020","unstructured":"Yang R, Jia Q, Li Y, Mehmood S (2020) Protective effect of exogenous hydrogen sulfide on diaphragm muscle fibrosis in streptozotocin-induced diabetic rats. Exp Biol Med (Maywood) 245:1280\u20131289. https:\/\/doi.org\/10.1177\/1535370220931038","journal-title":"Exp Biol Med (Maywood)"},{"key":"4636_CR254","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1111\/cts.13081","volume":"14","author":"N Ichinoseki-Sekine","year":"2021","unstructured":"Ichinoseki-Sekine N, Smuder AJ, Morton AB et al (2021) Hydrogen sulfide donor protects against mechanical ventilation-induced atrophy and contractile dysfunction in the rat diaphragm. Clin Transl Sci 14:2139\u20132145. https:\/\/doi.org\/10.1111\/cts.13081","journal-title":"Clin Transl Sci"},{"key":"4636_CR255","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cell.2018.03.001","volume":"173","author":"A Longchamp","year":"2018","unstructured":"Longchamp A, Mirabella T, Arduini A et al (2018) Amino acid restriction triggers angiogenesis via GCN2\/ATF4 regulation of VEGF and H2S production. Cell 173:117-129.e14. https:\/\/doi.org\/10.1016\/j.cell.2018.03.001","journal-title":"Cell"},{"key":"4636_CR256","doi-asserted-by":"publisher","unstructured":"Majumder A, Singh M, George AK et al (2018) Hydrogen sulfide improves postischemic neoangiogenesis in the hind limb of cystathionine\u2010\u03b2\u2010synthase mutant mice via PPAR\u2010\u03b3\/VEGF axis. Physiol Rep 6:e13858. https:\/\/doi.org\/10.14814\/phy2.13858","DOI":"10.14814\/phy2.13858"},{"key":"4636_CR257","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2019.33.1_supplement.831.5","author":"C Cain","year":"2019","unstructured":"Cain C, Devarakonda T, Thompson J et al (2019) Prevention and treatment of Duchenne cardiomyopathy with hydrogen sulfide-donor therapy. FASEB J. https:\/\/doi.org\/10.1096\/fasebj.2019.33.1_supplement.831.5","journal-title":"FASEB J"},{"key":"4636_CR258","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102040","volume":"45","author":"E Panza","year":"2021","unstructured":"Panza E, Vellecco V, Iannotti FA et al (2021) Duchenne\u2019s muscular dystrophy involves a defective transsulfuration pathway activity. Redox Biol 45:102040. https:\/\/doi.org\/10.1016\/j.redox.2021.102040","journal-title":"Redox Biol"},{"key":"4636_CR259","doi-asserted-by":"publisher","unstructured":"Saclier M, Ben Larbi S, My Ly H et al (2021) Interplay between myofibers and pro-inflammatory macrophages controls muscle damage in mdx mice. J Cell Sci 134:jcs258429. https:\/\/doi.org\/10.1242\/jcs.258429","DOI":"10.1242\/jcs.258429"},{"key":"4636_CR260","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/867273","volume":"2015","author":"M Rodr\u00edguez-Cruz","year":"2015","unstructured":"Rodr\u00edguez-Cruz M, Sanchez R, Escobar RE et al (2015) Evidence of insulin resistance and other metabolic alterations in boys with duchenne or becker muscular dystrophy. Int J Endocrinol 2015:867273. https:\/\/doi.org\/10.1155\/2015\/867273","journal-title":"Int J Endocrinol"},{"key":"4636_CR261","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1038\/s41598-022-07868-z","volume":"12","author":"P Podkalicka","year":"2022","unstructured":"Podkalicka P, Mucha O, Kazir\u00f3d K et al (2022) miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy. Sci Rep 12:3945. https:\/\/doi.org\/10.1038\/s41598-022-07868-z","journal-title":"Sci Rep"},{"key":"4636_CR262","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.pharep.2017.03.021","volume":"69","author":"L Tomasova","year":"2017","unstructured":"Tomasova L, Drapala A, Jurkowska H et al (2017) Na2S, a fast-releasing H2S donor, given as suppository lowers blood pressure in rats. Pharmacol Rep 69:971\u2013977. https:\/\/doi.org\/10.1016\/j.pharep.2017.03.021","journal-title":"Pharmacol Rep"},{"key":"4636_CR263","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/bs.mie.2014.11.014","volume":"554","author":"P Rose","year":"2015","unstructured":"Rose P, Dymock BW, Moore PK (2015) GYY4137, a novel water-soluble, H2S-releasing molecule. Methods Enzymol 554:143\u2013167. https:\/\/doi.org\/10.1016\/bs.mie.2014.11.014","journal-title":"Methods Enzymol"},{"key":"4636_CR264","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.phrs.2016.09.032","volume":"113","author":"CW Huang","year":"2016","unstructured":"Huang CW, Feng W, Peh MT et al (2016) A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo. Pharmacol Res 113:533\u2013546. https:\/\/doi.org\/10.1016\/j.phrs.2016.09.032","journal-title":"Pharmacol Res"},{"key":"4636_CR265","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.bmcl.2016.02.005","volume":"26","author":"S Xu","year":"2016","unstructured":"Xu S, Yang C-T, Meng F-H et al (2016) Ammonium tetrathiomolybdate as a water-soluble and slow-release hydrogen sulfide donor. Bioorg Med Chem Lett 26:1585\u20131588. https:\/\/doi.org\/10.1016\/j.bmcl.2016.02.005","journal-title":"Bioorg Med Chem Lett"},{"key":"4636_CR266","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002310","volume":"14","author":"A Dyson","year":"2017","unstructured":"Dyson A, Dal-Pizzol F, Sabbatini G et al (2017) Ammonium tetrathiomolybdate following ischemia\/reperfusion injury: chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models. PLoS Med 14:e1002310. https:\/\/doi.org\/10.1371\/journal.pmed.1002310","journal-title":"PLoS Med"},{"key":"4636_CR267","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/cr60234a004","volume":"65","author":"PS Landis","year":"1965","unstructured":"Landis PS (1965) The chemistry of 1,2-dithiole-3-thiones. Chem Rev 65:237\u2013245. https:\/\/doi.org\/10.1021\/cr60234a004","journal-title":"Chem Rev"},{"key":"4636_CR268","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1039\/C8PY00938D","volume":"9","author":"MC Urquhart","year":"2018","unstructured":"Urquhart MC, Ercole F, Whittaker MR et al (2018) Recent advances in the delivery of hydrogen sulfide via a macromolecular approach. Polym Chem 9:4431\u20134439. https:\/\/doi.org\/10.1039\/C8PY00938D","journal-title":"Polym Chem"},{"key":"4636_CR269","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2008.07.029","volume":"594","author":"R Baskar","year":"2008","unstructured":"Baskar R, Sparatore A, Del Soldato P, Moore PK (2008) Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 594:1\u20138. https:\/\/doi.org\/10.1016\/j.ejphar.2008.07.029","journal-title":"Eur J Pharmacol"},{"key":"4636_CR270","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1111\/j.1476-5381.2011.01704.x","volume":"165","author":"J Frantzias","year":"2012","unstructured":"Frantzias J, Logan J, Mollat P et al (2012) Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo: S-NSAIDs inhibit osteoclast-tumour cell interaction. Br J Pharmacol 165:1914\u20131925. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01704.x","journal-title":"Br J Pharmacol"},{"key":"4636_CR271","doi-asserted-by":"publisher","first-page":"4196","DOI":"10.1021\/acs.orglett.5b01962","volume":"17","author":"D Liang","year":"2015","unstructured":"Liang D, Wu H, Wong MW, Huang D (2015) Diallyl trisulfide is a fast H2S donor, but diallyl disulfide is a slow one: the reaction pathways and intermediates of glutathione with polysulfides. Org Lett 17:4196\u20134199. https:\/\/doi.org\/10.1021\/acs.orglett.5b01962","journal-title":"Org Lett"},{"key":"4636_CR272","doi-asserted-by":"publisher","first-page":"7501","DOI":"10.1021\/acs.jmedchem.5b01033","volume":"58","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Yang C, Organ C et al (2015) Design, synthesis, and cardioprotective effects of n-mercapto-based hydrogen sulfide donors. J Med Chem 58:7501\u20137511. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01033","journal-title":"J Med Chem"},{"key":"4636_CR273","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1021\/ol500385a","volume":"16","author":"JC Foster","year":"2014","unstructured":"Foster JC, Powell CR, Radzinski SC, Matson JB (2014) S-Aroylthiooximes: a facile route to hydrogen sulfide releasing compounds with structure-dependent release kinetics. Org Lett 16:1558\u20131561. https:\/\/doi.org\/10.1021\/ol500385a","journal-title":"Org Lett"},{"key":"4636_CR274","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1021\/ml400239a","volume":"4","author":"A Martelli","year":"2013","unstructured":"Martelli A, Testai L, Citi V et al (2013) Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in vitro and in vivo. ACS Med Chem Lett 4:904\u2013908. https:\/\/doi.org\/10.1021\/ml400239a","journal-title":"ACS Med Chem Lett"},{"key":"4636_CR275","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1021\/ol401118k","volume":"15","author":"NO Devarie-Baez","year":"2013","unstructured":"Devarie-Baez NO, Bagdon PE, Peng B et al (2013) Light-induced hydrogen sulfide release from \u201cCaged\u201d gem-dithiols. Org Lett 15:2786\u20132789. https:\/\/doi.org\/10.1021\/ol401118k","journal-title":"Org Lett"},{"key":"4636_CR276","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1039\/C3CC47421F","volume":"50","author":"N Fukushima","year":"2014","unstructured":"Fukushima N, Ieda N, Sasakura K et al (2014) Synthesis of a photocontrollable hydrogen sulfide donor using ketoprofenate photocages. Chem Commun 50:587\u2013589. https:\/\/doi.org\/10.1039\/C3CC47421F","journal-title":"Chem Commun"},{"key":"4636_CR277","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1002\/anie.201511244","volume":"55","author":"Y Zheng","year":"2016","unstructured":"Zheng Y, Yu B, Ji K et al (2016) Esterase-sensitive prodrugs with tunable release rates and direct generation of hydrogen sulfide. Angew Chem Int Ed 55:4514\u20134518. https:\/\/doi.org\/10.1002\/anie.201511244","journal-title":"Angew Chem Int Ed"},{"key":"4636_CR278","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202103525","author":"CC Jimidar","year":"2022","unstructured":"Jimidar CC, Grunenberg J, Karge B et al (2022) Masked amino trimethyl lock (H2N-TML) systems: new molecular entities for the development of turn-on fluorophores and their application in hydrogen sulfide (H2S) imaging in human cells. Chem A Eur J. https:\/\/doi.org\/10.1002\/chem.202103525","journal-title":"Chem A Eur J"},{"key":"4636_CR279","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fphar.2017.00664","volume":"8","author":"C-T Yang","year":"2017","unstructured":"Yang C-T, Chen L, Xu S et al (2017) Recent development of hydrogen sulfide releasing\/stimulating reagents and their potential applications in cancer and glycometabolic disorders. Front Pharmacol 8:664. https:\/\/doi.org\/10.3389\/fphar.2017.00664","journal-title":"Front Pharmacol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04636-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04636-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T16:32:09Z","timestamp":1728491529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04636-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":279,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4636"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04636-0","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"assertion":[{"value":"2 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"608"}}